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I, GENERAL - Acetylsalicylic acid known popularly as 
aspirin is probably the most widely used drug either singly 
or in combination with other drugs (Gi5)ta and Gi:5)ta, 1977). 
It is the most extensively employed analgesic, antipyretic 
and anti-inflammatory agent (Kato et al.. 1982), Although 
adverse reactions to its lase are rare, they are nevertheless 
not very uncommon because of the universal use of this 
"everyman's medicine" (Fienguy _et al», 1972a), As a thera-
peutic agent aspirin presents something of a paradox. The 
layman relies i;pon it as the common household analgesic, yet 
because the drug is inexpensive and readily available, he 
often underrates its analgesic efficacy (Woodbury and Fingl, 
1975). Since the introduction of aspirin in the middle of 
nineteenth century, there have been as many reports claiming 
more effective analgesia for it, when compared with sodium 
salicylate, as there have been those disclaiming si?)erior 
analgesia (Gross and Greenb\arg, 19^; Smith, 1960; Lasagna, 
1961; Dixon, 1963; Seed, 1965). 
In 1827 Leroux isolated a bitter glycoside called 
salicin from the willow bark (salix alba), the antipyretic 
property of which was known to the ancients. Salicin libe-
rates glucose and salicylic alcohol (saligenin) on hydrolysis, 
?or the first time Piria (1938) obtained salicylic acid 
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(orthohydroxybenzoicacid) from salicin. Six years later, 
salicylic acid was prepared from oil of gaultheria (oil of 
Wintergreen) by Cahours, The manufacture of salicylic acid 
from phenol was accomplished in 1860 by Kolbe and Lautemann. 
Dreser introduced ASA for therapeutic use in the year 1899 
(Woodbury and Fingl, 1975). 
Salicylic acid is highly irritating to the digestive 
system (Kitamura and Maxima, 1983) and can be only usedfor 
surface application. Various derivatives of this acid have 
therefore, been synthesized for systemic use. Aspirin is 
an ester of salicylic acid in which the carboxyl group of 
salicylic acid is retained and the hydroxyl group is acetyla-
ted. Salicylates generally act by virtue of their salicylic 
acid content, althou^ some of the effects of aspirin are 
related to its ability to acetylate protein (Woodbury and 
Fingl, 1975). 
II. THERAPEUTIC USES OF ASPIRIN - Salicylates are more 
widely used for pain relief than any other class of drugs. 
There are many systemic and a few local uses of the salicy-
lates. Several are based on the traditional and empirical 
results rather than on a clear understanding of the mechanism 
of therapeutic benefit. The pharmacologist and clinician 
praise the efficacy and safety of aspirin as an analgesic and 
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antirheumatic agent. They, however, find it necessary to vam 
constantly of its role as a common cause of lethal drug jxjison-
ing in young children and serious toxicity in adults* 
Aspirin is invaluable for the relief of certain types 
of pain, like headache and pain associated with arthritis, 
neuralgia and myalgia, Glassman et al,(1982) have compared 
the effect of the meprobamate-aspirin combination (Micrainin) 
with aspirin alone for relief of muscle contraction headache. 
They concluded that Micrainin was significantly more effective 
than aspirin in relieving the symptom complex of muscle con-
traction headache. 
The effect of salicylates on respiration is of para-
mount importance because they stimulate respiration directly 
and indirectly. Full therapeutic doses of salicylates 
increase oxygen consumption and carbon dioxide production in 
experimental animals and man as a result of salicylate in-
duced uncoupling of oxidative phosphorylation (Spenney and 
Nowell, 1979). 
Woodbury and Fingl (1975) have reported that in the 
case of acute rheumatic fever, the salicylates supress the 
exudative inflammatory processes of the disease but do not 
effect the progression of the disease or the later phase of 
granulomatous inflammation or scar formation. Despite the 
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development of several newer agents , s a l i cy l a t e s are s t i l l the 
cornerstones of therapy and the drugs of f i r s t choice for the 
treatment of rheumatoid a r t h r i t i s (Binus e t aJ.,, 1982) and 
disorders (Simon and Mi l l s , 1980), Sa l i cy la tes have been 
shown to produce object ively measurable anti-inflammatory 
changes vdien given in large doses for long periods to pa t i en t s 
with acute rheumatoid a r t h r i t i s (Boardman and Hart , 1967; 
Deodhar e t a l . , 1973). In addit ion to the analgesia t ha t 
allows more effect ive therapeutic exerc ises , there i s improve-
ment in appe t i te and a fee l ing of well-being. Sa l icy la tes also 
reduce the inflammation of the jo in t s and surrounding t i s s u e s . 
Hope e t a l , (1975) have presented evidence t h a t b i o -
synthes is of prostaglandins PGE2» PGF^ j^^  and PGE^  from p l a t e -
l e t s i s st imulated in vitamin E - d e f i c i e n t r a t s . If the syn-
the s i s of prostaglandins plays a s ign i f i can t ro le in the 
development of jjathology in specif ic t i s sues of vitamin E -
def ic ien t animals, these drugs v4iich i n h i b i t prostaglandin b i o -
synthes is m i ^ t ameliorate or exacerbate the manifestation of 
a vitamin E-deficiency, depending on the nature of the t i s sue 
(Nelson e t a l . , 1980), Aspirin i s a well known i n h i b i t o r of 
prostaglandin biosynthesis (Vane, 1971; Vane, 1974; Flower, 
1974), Aspirin and re la ted anti-inflammatory drugs and platei-
l e t s (Smith and Wi l l i s , 1971) prevent the synthesis of p ros ta -
glandins from arachidonic acid in various t i s sue homogienates 
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(Vane, 1971) and in te r fere with i t s l i be ra t ion from spleen 
(Ferrei ra e t a l , , 1971). 
In recent years , the mechanism of a s p i r i n ' s a n t i -
p l a t e l e t e f fec t i . e . ace ty la t ion and inh ib i t ion of p l a t e l e t 
cyclooxygenase (a prostaglandin synthetase) has been c l a r i f i ed 
(Burch e t a l . , 1978; Roth and Majenis, 1975). There i s a l so 
ava i l ab l e , compelling evidence tha t the anti-inflammatory 
proper t ies of ASA are a t l e a s t p a r t i a l l y re la ted to a s imi l a r -
ly mediated inh ib i t ion of prostaglandin synthetase (s) a t 
l oca l t i ssue s i t e s (Whiting e t a^, , 1980). The i n t a c t ASA 
molecule unlike i t s primary metaboli te , s a l i c y l a t e , i s r e s -
ponsible for the t ransace ty la t ion react ions v±iich lead to the 
inh ib i t ion of these enzymes. Therefore, fac tors effect ing 
the duration of ASA survival in vivo are po ten t i a l ly impor-
t a n t , Bailey et a l , (1979) have also reported that a sp i r in 
has the a b i l i t y to i n h i b i t the cyclooxygenase en2ymes tha t 
convert arachidonic acid to the cycl ic endoperoxide i n t e r -
mediate and thus prevents the synthesis of the proaggregatoiT" 
substance TXAp in p l a t e l e t s . Aspirin and a number of drugs 
having th i s property have been tes ted both in c l i n i c a l t r i a l s 
and in animal studies for t h e i r a b i l i t y to i n h i b i t a the ro -
genesis and myocardial in fa rc t ion . Aspirin i s knovai to i r r e -
vers ib ly i n h i b i t the cyclooxygenase by ace ty la t ing the enzyme 
(Roth and Majerus, 1975). Aspir in- t rea ted c e l l s do not 
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produce prostacyclin in response to thrombin, despite full 
recovery of the cyclooxygenase. This indicates that aspirin 
also inactivates additional components of the prostacyclin 
releasing system that are not continuously replaced in the 
resting cells (Whiting et al., 1980), Prostacyclin (PGI2) 
and aspirin are potentially effective in correcting certain 
of the pathological sequelae of diabetes mellitus (Waitzman 
etal., 1977; Waitzman, 1979). 
Aspirin is used widely as an anticoagulant. It has 
been preferred over heparin both for efficacy and safety 
(Dodds, 1982). ASA has been found to be of value in the 
treatment of thromboembolic vascular diseases because of its 
antiplatelet effect (Costello et al., 1984), The value of 
anticoagulation with dicumarol and warfain to avoid thrombo~ 
embolic complications in patients with tendency to form clots 
including those with prosthetic heart valves has been well 
established (Bjork and Henze, 1975). The cumulative experience 
indicates that in children with prosthetic cardiac valves, 
aspirin provides adequate protection against thromboemboli and 
prevents haemorrhagic complications associated with warfain 
(Weinstein et al,, 1982). Antiplatelet drugs, such as ASA and 
dipyridamole, have been used extensively as alternatives to 
warfain because they are safe, inexpensive, easy to administer 
and they require no laboratory tests for their regulation. 
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In children a s ingle ora l dose of asp i r in (30 mg/kg) i nh ib i t s 
p l a t e l e t aggregation. Woodbury and Fingl (1975) have s t a t ed 
t h a t the prophylactic administrat ion of a sp i r in exerts a pro-
t ec t ive ef fect equivalent to t ha t of o ra l ant icoagulants 
aga ins t venous thrombosis and pulmonary embolism in pa t i en t s 
undergoing ce r t a in orthopaedic operat ions. The EPSIM research 
group (1982) have shown that dosage of a s p i r i n used i s pro-
bably not d i f ferent from ora l anticoagulant i n effect ing 
mortal i ty and morbidity a f t e r a myocardial in fa rc t ion . 
Some inves t iga tors have reported t h a t a s p i r i n decreased 
or eliminated the hypercalcemia associated with ce r t a in types 
of cancer (Seyberth _et aJ,,, 1975) Or with the admihistrat ion 
of A^-On vitamin D, (Ueno e t a l , , 1980), Other inves t iga -
t o r s have demonstrated tha t large doses of a sp i r i n cause hypo-
calcemia in normal r a t s a f t e r i . p . (Kawashima et a l , , 1980) 
and P.O. administrat ion (Ueno e t a l , , 1981), The inh ib i tory 
e f fec t of a sp i r in and indomethacin on pathological hyper-
calcemia were re la ted to inh ib i t ion of the biosynthesis of 
endogenous prostaglandins (Seyberth e t a l , , 1975), because 
these two drugs are potent inh ib i to r s of p r o s t a g l ^ d i n synthe-
tase (Vane, 1971), 
I I I . ASPIRIN ESTERASE - Since ASA i s the most commonly used 
pharmacological agent, numerous s tudies l:iave defined the 
pharmacokinetics of t h i s drug (Rowland e t a l , , 1967), Meta-
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bo lie conversion of ASA to salicylic acid (Howes and Hianter, 
1968) and salicyl\iric acid (Levy, 1968) are well known. 
Relatively few studies are, however, available on the enzyma-
tic basis of these transformations (Rowland ei a^., 1967) 
and characterization of enzyme(s) responsible for the con-
versions, _In vivo hydrolysis of ASA appears to be a complex 
phenomenon. Some enzymes, capable of hydrolyzing ASA, are 
present in the plasma and various tissues and they may be 
important in determining the pharmacological and toxicologi-
cal properties of this drug, especially in disease states 
(Menguy _et al,, 1972a,b; Vincent and Lagreu, 1949; Morgan 
and Truitt, 1965j Landecker et al,, 1977; Rainsford, 1977; 
Rainsford, 1978), The rate of conversion of ASA to salicylate 
in vivo may be important since ASA and salicylic acid differ 
in their pharmacological action. For instance, on molar basis 
ASA is (a) more potent as an analgesic and anti-inflammatory 
agent, (b) more ulcerogenic, especially caxising gastric ulcers 
and (c) much more effective as an inhibitor of prostaglandin 
biosynthesis and platelet aggregation than salicylate (Lim 
et al,, 1964; Flower, 1974; Mills et al,, 1974; Rainsford, 
1975; Tmavsky and Zachar, 1975). 
Lester et al, (1946) reported for the first time that 
plasma could hydrolyze ASA but they gave no data and did not 
speculate if the process was enzymatic. The report of 
Vandelli and Scaltriti (1943) recognized the presence of an 
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a c e t y l s a l i c y l i c acid es terase in several t i s sues other than 
blood. Smith (1946) a lso demonstrated the hydrolysis of ASA 
by several t i s s u e s . The enzyme tha t catalyzes the hydrolysis 
of a c e t y l s a l i c y l i c acid to s a l i c y l i c acid and free ace ta te i s 
referred to as "aspir in es te rase" (Rainsford e t al«« 1980) 
(Figure 1 ) . Despite i t s specif ic denotion ASA estei^ase may, 
however, not be a single enzyme but belongs to a group of 
enzymes (Schroeter and Amon, 1980), Spenney (1977) has termed 
t h i s enzyme from gas t r ic mucosa as " ace ty l s a l i cy l i c acid 
hydrolase", ASA esterase i s present in the plasma, serum, 
l i v e r and kidney (Vandelli and S c a l t r i t i , 1943). The presence 
of th i s enzyme has also been reported in gas t r ic liiucosa 
(Whitecross e t a3L,, 1977) and small i n t e s t i ne (Curry, 1977), 
Several l ines of evidence suggest tha t the ga s t ro in t e s t i na l 
mucosa may be important in the hydrolysis of ASA (Levy e t a l , , 
1967), Pharmacokinetic s tudies of Harris and Reigelman (1969) 
showed that the hydrolysis of ASA was more extensive following 
o r a l administrat ion than follov/ing infusion in to the portfil 
ve in . Levy et a l , (1967) studying the effects of lumenal 
a c e t y l s a l i c y l i c acid in glucose and amino acids absorption by 
i n t e s t i n e in vivo, noted tt iat the drug i so la ted from the se ro -
s a l solut ion had been hydrolyzed to a much gi'eater extent than 
t h a t exposed only to heat denatured i n t e s t i n e . Studies by 
Spenney and Nowell (1979) and Builder jet a l , (1977) have 
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demonstrated ASA hydrolase a c t i v i t y in gas t r ic mucosa. In an 
e a r l i e r study ASA hydrolase a c t i v i t y was demonstrated in a l l 
por t ions of the gas t ro in te s t ina l t r a c t (Nowell and Spenney, 
1978). 
Guinea pig l i v e r homogenate contains s ign i f i can t ly 
h i ^ e r a b i l i t y to hydrolyze ASA than serum or plasma (Vincent 
and Lagreu, 1949). ASA hydrolysis by mammalian t i s sues and 
plasma has been a t t r i bu t ed to "acetyles terases" d i s t ingu i sh -
ab le from cholinesterases by inh ib i t ion proper t ies (Morgan 
and T r u i t t , 1965). Extensive work has been performed on the 
es te rases of l i v e r (Heymann, 1980) indica t ing t h e i r broad 
subs t ra te s p e c i f i c i t i e s , including hydrolyt ic a c t i v i t y towards 
th ioes te r s and some amides. White and Hope (1981) did not 
succeed in locat ing as to v^ich of these enzyme(s),if any, was 
responsible for ASA hydrolysis hi vivo. 
Pharmacokinetic s tudies of Harris and Riejgelman (1969) 
i n dog, Iwamoto et al_. (1982) in r a t and of Rowland e t a l . 
(1967, 1972) iri man have establ ished gut and l i v e r as the two 
important s i t e s of ASA hydrolysis on i t s f i r s t pass from the 
stomach to the c i rcu la t ion a f t e r o ra l adminis t ra t ion. In m£in 
i t was establ ished that 405^  of a single dose of ASA may be 
hydrolyzed on i t s f i r s t pass t h r o u ^ the l i v e r (Rowland e t a l . . 
1972). Organ survey of ASA hydrolyzing a c t i v i t i e s in i n d i v i -
dual species has shown tha t l i v e r and in tes t ine ; have h i ^ 
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spec i f i c a c t i v i t i e s compared to other t i ssues in several 
animal species . This i s true in case of guinea pig (Vincent 
and Lagreu, 19^9), man (Put ter , 1976) and rabb i t (Nowell and 
Spenney, 1978). Spenney and Novell (1979) pur i f ied the p re -
dominant ASA hydrolyzing a c t i v i t y of gas t r i c mucosa to homo-
geneity, but made no attempt to es tab l i sh tiie i den t i t y of the 
enzyme, A single carboxylesterase capable of hydrolyzing 
ASA was iden t i f i ed in human i n t e s t i n a l mucosa and was pur i f ied 
to homogeneity by Inoue e t a l , (1979). I t was, however, not 
c l e a r whether t h i s was the main ASA hydrolyzing enzyme in th i s 
t i s s u e . White and Hope (1984) have described a cytoplasmic 
carboxylesterase specif ic for ASA from guinea pig l i v e r and 
confirmed tha t ASA hydrolyzing a c t i v i t y in the nijelear and 
mitochondrial c e l l f ract ions i s due to the microsomal ASA 
hydrolase. 
Eyring and Ford (1972) foimd an ASA s p l i t t i n g es terase 
i n the 9000 x g soluble supernatant of several human t i s sues 
and in t i ssues of several other animal species . Schroeter 
and Aroon (1980) studied the ASA esterase a c t i v i t y in human 
f e t a l o r ^ n s during development. All the f e t a l organs studied 
exhibited ASA s p l i t t i n g es terase a c t i v i t y . An ontogenic 
survey of human t i ssues indicated tha t the a c t i v i t y increases 
during in t rau te r ine development. When subjected to c e l l -
f rac t iona t ion highest a c t i v i t y of ASA es terase was found in 
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the 10,5,000 X g supernatants rather than the microsomal 
rraction. Eyring et al. (1973) have also demonstrated an 
increase in ASA splitting esterase activity in rabbit 
fetal liver and kidney. The adult liver, however, con-
tained far higher activity than the fetal liver* 
ASA hydrolyzing capacity of blood plasma and serum 
has attracted considerable attention over the last several 
years. For the first time Lester _et al. (1946) demonstrated 
this ASA esterase activity in the serum. The role of this 
enzyme in ASA metabolism has been recognized by several 
workers (Vincent and Parant, 1950; Mulinos and Ardam, 1950; 
Beckman, 1956). ASA esterases differ from acetylcholines-
terase in that they are slightly inhibited by eserine, inhi-
bited by DFP, unaffected by cyanide ions and destroyed by 
boiling (Vincent and Lagreu, 1949, 1950; Glasson, 1951; 
Edwards, 1952). Serum ASA esterase has been shown to differ 
from the pseudocholinesterase of serum (Augustinsson, 1948; 
Augustinsson and Nachmansohn, 1949; Bastide, 1955). The 
compound bis-(4-nitrophenyl hydrogen phosphate), a specific 
inhibitor of carboxylesterases but not of other serine hy-
drolases such as proteinases (Heymann and Krisch, 1967), 
has also been used to characterize the enzyme responsible 
for ASA hydrolysis in guinea pig liver (White and Hope, 1981) 
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I t has been establ ished by Rowland and Riegelman 
(1968) tha t ASA esterase a c t i v i t y in human blood volume 
accounts for about 209^  of the t o t a l hydrolysis of a dose of 
ASA with the remaining taking pa r t in the l i v e r , Tmavsky 
and Zachar (1975) have corre la ted the a c t i v i t y of ASA 
es te rase in plasma with the half-t ime and r a t e of elimination 
of sa l i cy la t e and showed tha t t h i s enzyme a c t i v i t y could 
determine the non-spontaneous conversion of ASA to s a l i c y l a t e . 
Quick (1966) and O'Brien (1968) have a lso observed tha t 
in jur ious effects of ASA are mostly due to the i n t a c t mole-
cule ra ther than i t s breakdown product and t h a t any defect in 
ASA metabolism may contr ibute greatly to such i n j u r i e s . 
Difference in plasma ASA esterase a c t i v i t y between males 
and females of several species of animals and human beings has 
been reported by several workers, ABA hydrolyzing a c t i v i t y 
was found to be much lower in plasma of female subjects than 
in males (Gupta and Gupta, 1977). Many Austra l ian s tudies 
have establ ished tha t gas t r ic i i lceration re la ted t o ASA con-
sumption i s more prevalent among women than among men 
(Bi l l ington , 1963; Duggan and Chapman, 1970), I t was a lso 
observed by Collins and Turner (1975) tha t there was an 
increased incidence of maternal anaemia, ante-partum haemorr-
hage, prolonged gestat ion, e t c . in a group of pregnant women 
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who were habi tual users of ASA, Menguy and co-workers (Menguy 
e t a l . , 1972a,b; Vincent and Lagreu, 19^9; Morgan and T r u i t t , 
1965) have suggested tha t the depression in plasma ASA 
es te rase observed in women and pa t ien ts witli a lcohol ic l i v e r 
disease may be re la ted to the increased propensity of these 
two groups to gas t r ic u lcera t ion and haemorrhage, Rainsford 
e t a l . (1980), however, did not detect any difference between 
the sexes. While the level of ASA esterase in the pa t i en t s 
with a lcohol ic l i v e r disease were comparable with normal 
ind iv idua l s , those with rheumatoid a r t h r i t i s administered with 
gold s a l t or D(-)penicillamine exhibited elevated ASA es terase 
l e v e l s . The reported differences in plasma ASA es terase between 
the sexes, in pa t ien t s with alcoholic l i ve r disease and in 
pa t i en t s with rheumatoid a r t h r i t i s were inves t iga ted . The l a t t e r 
group comprisesan appreciable proportion of the population, 
r e q u i r e s h i ^ doses of ASA and i s known to have defects in 
l i v e r metabolism (Kendall et aX,, 1971; Hilton e t a l , , 197^). 
This m i ^ t r e f l e c t the capacity of th i s organ to produce ASA 
hydrolyzing enzymes under some s t r e s s conditions (Menguy e t a^, , 
1972b; Kendall e t a l . , 1971). Work carr ied out in t h i s l abora-
tory a lso does not show any s ign i f ican t difference in the t o t a l 
blood ASA esterase leve ls of male and female subjects among the 
l oca l population (Mohan e t ^ , , 1986), 
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The hypothesis tha t the en t i r e ASA molecule i s the 
ac t ive moiety in ASA analgesia focussed the a t t en t ion on 
fac tors cont ro l l ing blood ASA concentration. These fac tors 
include the ra te of absorption, d i s t r ibu t ion to t i s s u e s , 
hydrolysis and ra te of urinary excret ion. The r a t e of hydroly-
s i s could be tested _in v i t ro free of other fac tors /which 
cont ro l blood ASA concentration, 
Rylance and Wallace (1981) have shown tha t a large 
f rac t ion of the ASA esterase a c t i v i t y of vdiole blood could be 
located in the c e l l u l a r f rac t ion and suggested that the enzyme 
ins ide the red c e l l and plasma may be d i f fe ren t . They believed 
t h a t the c e l l u l a r enzyme i s a r e l a t i v e l y non-specific es terase 
whereas the plasma enzyme a c t i v i t y i s due to chol ines te rase . 
In normal whole human blood the ra te of a c e t y l s a l i c y l i c acid 
deacetyla t ion was closely linked to the concentration of RBCs 
(Costello and Green, 1982), The sajjie workers (Costello and 
Green, 1983) reported tha t the RBC-relaited ASA es terase was 
located in t r ace l lu l a ry in the red ce l l s and not r e la ted to 
membrane ace ty lchol ines terase . 
The importance of RBC-related ASA es terase in terms of 
i t s in vivo role in cont ro l l ing ASA survival has been e s t a b l i -
shed by Costello e t a l . (1984), In v i t r o , the ra tes of ASA 
hydrolysis were r e l a t i ve ly slow in plasma from human and dogs. 
The hydrolysis r a t es were s ign i f i can t ly greater in whole blood. 
In human and canine whole blood, the ra te of hydrolysis co r re -
l a t ed pos i t ive ly with hematocrit . 
MTSRIALS 
Chemicals used for the present s tudies were 
obtained from the sources given against t h e i r names. 
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Chemical Source 
Acetic anhydride 
Acetoni t r i le 
Acetylcholine iodide 
Acetylthiocholine iodide 
Acrylamide 
Agarose 
4-Amino salicylic acid 
5-Amino salicylic acid 
Ammonium persulfate 
Bis-(p-nitrophenyl) 
phosphate 
Blue dextran 
Bovine serum albumin 
Bromophenol blue 
Casein 
Catalase 
B.D.H., India. 
Merck, India. 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co,^ , U.S.A. 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
May & Baker Ltd.,, Shgland. 
Sigma Chemical Co., U.S.A. 
Pharmacia Fine Chemicals, 
Sweden, 
Sigma Chemical Ck)., U.S.A. 
B.D.H., England, 
Difco Laborator ies , U.S.A, 
CSIR Centre for Biochemicals, 
V.P. Chest I n s t i t u t e , India . 
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Coomassie b r i l l i a n t blue 
G-250 
Coomassie b r i l l i a n t blue 
R-250 
Cyanogen bromide 
Cysteine hydrochloride 
Cytochrome C 
Diethylaminoethyl cel lulose 
D iethanolamine 
5 ,5 ' -Di th iob is 
(2-nitrobenzoic acid) 
Ethylenediaminetetra-acetic 
acid 
Eserine 
Ferr ic n i t r a t e 
Folin-phenol reagent 
Freund's complete adjuvant 
Goat-ant i r abb i t IgG alkal ine 
phosphatase conjugate 
Hydroxylamine hydrochloride 
lodoacetamide 
Sigma Chemical Co., 
U.S.A. 
Sigma Chemical Co., 
U.S.A. 
Sisco Research 
Laboratories , India. 
Centron Re sear ph 
Laboratories , India . 
Sigma Chemical Co., 
U.S.A. 
Reanal, Hungary. 
Sigma Chemical Co., 
U.S.A. 
Sigma Chemic^ Co., 
U.S.A. 
B.D.H., India. 
Sigma Chemical Co., 
U.S.A. 
Sarabhai M. Chemicals, 
India, 
Sigma Chemical Co., 
U.S.A. 
Difco Laboratories, 
U.S.A. 
Sigma Chemical Co., 
U.S.A. 
Rudipont Indus t r i a l 
Co., I t a l y . 
Sigma Chemical Co., 
U.S.A. 
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Marker prote in for SDS 
elect rophores is 
2-Fiercaptoe thanol 
N, N' -Methylene b i s ac ry l -
amide 
Orthophosphoric acid 
Ovalbuunin 
P henyIme thy1sulfony1-
flt toride 
p-Nitrophenyl phosphate 
Pyronin Y 
Ribonuclease 
Sa l icy l ic a c i i 
Sephadex G-200 
Sepharose 4B 
Sodium 5 ,5-d ie thylbarb i -
t ura te 
Sodiiim dodecyl su l fa te 
Sucrose 
N, N, N»-N'-Te trame thylene 
d iamine 
Tris(hydroxymethyl)amino 
methane 
Trypsin 
Tween-20 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
B.D.H., England. 
B.D.H., India. 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co *, U.S.A. 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
B.D.H., India. 
Pharmacia Fine Chemicals, 
Sweden. 
Pharmacia Fine Chemical.s, 
Sweden. 
Hopkins & Williams, lihgland. 
Sigma Chemical Co., U.S.A. 
B.D.H., India , 
B.D.H., India . 
Sigma Chemical Co., U.S.A. 
Sigma Chemical Co., U.S.A. 
Koch-Light Laboratories, 
England, 
Urea B.D.H., India, 
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METHODS 
Preparation and Crys ta l l iza t ion o£ ASA - ASA was 
synthesized and pxorified by the standard procedure (Vogel, 
1955). Concentrated sulfur ic acid was added dropwiae to 
10 gm Sal icyl ic acid dissolved in 14 ml acet ic anhydride. 
The solution was continuously s t i r r ed a t 50-60 for about 
15 minutes, cooled and 150 ml d i s t i l l e d water was added. 
The p rec ip i t a ted ASA Was f i l t e r e d through a Buchner funnel. 
The ASA preparat ion was pur i f ied by repeated c r y s t a l l i z a -
t i on from ethanol . 
Assay of ASA Esterase - ASA esterase a c t i v i t y in blood 
and other preparat ions was determined using the procedure 
described by Trinder (1954) as modified by Gupta and Gupta 
(1977). lb 0.5 ml c i t r a t e d blood or other samples, was 
added, 0,5 ml freshly prepared ASA solut ion (300 tag% in 
0.05M Tris-HCl, pH 8,5) and 2.0 ml of 0.05M Tris-HCl 
buffer, pH 8 , 5 . The mixture was incubated in a water bath 
a t 37° with occasional shaking, 3.0 ml of acidic mercuric 
ch lor ide- fe r r ic n i t r a t e (HgCl2-Fe(N0,),) solut ion was added 
a t the end of incubation period to each tube, the contents 
were agi ta ted vigorously and centrifuged a t 3000 r .p.m, for 
15 minutes. Colour of the supernatant was read immediately 
a t 540 nm against a reagent blank. 
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For each sample an appropriate blank was used to 
eliminate endogeno\as ASA hydrolysis. The corrected absor-
bance for each sanple was then used tor the determination 
of the equivalent salicylic acid from a standard' graph. 
Pure salicylic acid was used for the preparation of a 
standard curve. One unit of ASA esterase activity is the 
amount of enzyme that causes the production of 1 pmole of 
salicylic acid/hour under the standard conditions. 
activity 
Values of ASA esterase/[given in the thesis, unless 
otherwise indicated, represent the average of at least 
2 independent and closely agreeing experiments performed 
in duplicate. 
Preparation of HgClg (FeNO^), Solution - Tlrie colour re a-
Was 
gent used in the assay/prepared by dissolving 10 gm mer-
curic chloride in 170 ml hot distilled water. The solu-
tion was cooled and 60 ml of 1M HCl and 10 gm FeCNO^),, 
9HpO were added. When all the ferric nitrate had dissolv-
ed, the volume was made upto 250 ml with distilled water. 
The reagent could be stored indefinitely. 
Blood - Outdated human blood obtained from the local 
Medical College or fresh blood donated by apparently 
healthy volunteers was used. Plasma was separated by 
c entrifugation and RBCs were washed several times wi-th 
normal saline prior to use. 
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Preparat ion o£ Hemolvzate and Erythrocyte Crhpsts - The 
membrane-free hemolyzate was prepared by hemolyzing the 
washed RBCs in 5 mM Tris-HCl, pH 7A. Hemoglobin-free 
RBC ghosts were obtained by repeated washing of the 
membranes with hypotonic buffer solut ion (Dodge j | i a.1.. 
1963). 
Column Chromatography -
(a) DEAE-cellulose chromatography: Appropriate amount 
of DEAE-cellulose was suspended with 15 volumes of 0.5N 
HCl for half an hoior and washed in a Biichner funnel. 
The washing was continued t i l l the pH of the f i l t r a t e was 
approximately 4 ,0 . The exchanger was then t rea ted with 
15 volumes of 0,5 N sodium hydroxide for half an hour and 
the washing continued t i l l the pH of the f i l t r a t e app-
roached n e u t r a l i t y . The DEAE-cellulose was then r e s u s -
pended in operating bxiffer to get a homogoaous s l i i r ry . 
Fine p a r t i c l e s were removed and cel l i i lose was p a r t i a l l y 
dr ied on a Buchner funnel. To the semi-wet DEAE-cellulose 
was added requ i s i t e amount of RBC hemolyzate, obtained by 
mixing one voliime of RBC with six volumes of d i s t i l l e d 
a 
water. The suspension was s t i r r e d on/magnetic s t i r r e r 
a t 4° for 6 hours. The s lur ry was subsequently washed with 
cold 0,05M Tris-HCl buffer, pH 7.5 t i l l the supernatant 
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obtained was free of pro te in a t 280 nm. Hemoglobin and 
many other prote ins were eliminated af te r extensive wash-
ing . The enzyme bound sl\arry was poured in a cleian v e r t i -
ca l ly moxmted ^jacketed column to a bed volume of 212 ml 
(3 .0 X 30 cm). The flow r a t e was gradually increased to 
35 ml/hour. The coliimn was thai equi l ibra ted with' excess 
of the operating buffer t i l l the pH of the eff luent was 
iden t i ca l to tha t of e lu t ing buffer, Elution was perform-
a 
ed wi th / l inear gradient ( 0 . 2 - 1.0M) of N a a in 0,05 M 
Tris-HCl, pH 7 ,5 . 5.0 ml f rac t ions were col lected and 
assayed for enzyme ac t iv i ty and pro te in , NaCl concentra-
t ion in various f ract ions was determined by conductivity 
measurements, 
(b) Sephadex column chromatography: A coluinn of 
Sephadex G-200 was prepared as recommended by Peterson 
and Sober (1962). Sephadex G~200 was allowed to swell 
in a su i table amount of d i s t i l l e d water for 5 hoiirs in a 
boi l ing water bath, A previously cleaned g lass column 
was mounted v e r t i c a l l y and glass wool plugged alongwith 
g lass beads a t the bottom of the column. The coliomn was 
f i l l e d to one thiixi of i t s length with the operating 
buffer . The deaerated gel s lur ry was then gently poured 
in to the column with the help of a glass rod, Ihe column 
was l e f t standing overnight. Flow r a t e was subsequently 
increased gradually with the help of stopcock. After 
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accon5)lishing a constant r a t e o£ flow higher than required 
for f i na l e lu t ion , the column was adjusted to the required 
flow r a t e , Ihe coliimn was t ho rou^ ly washed with two bed 
volumes of operating biiffer (0.05M Tris-HCl, pH 7 .5 ) . In 
order to determine the uniform packing and void Volume (Vo) 
of the column, 2.0 ml of 2% (w/v) blue dextrah was passed 
through the column. The buffer was careful ly removed from 
the surface and prote in sample applied. The volume of 
blue dextran and prote in applied on the column was not 
more than 2-3 percent of the t o t a l bed volume of the column. 
Sephadex columjis were packed a t 4 for enzyme p u r i -
f i c a t i on and for molecular weight determination a t room 
temperature. 
Protein Estimation -
(a) Coomassie b r i l l i a n t blue binding method: Protein was 
estimated by the dye-binding n^thod of Bradford (1976), using 
coomassie b r i l l i a n t blue G-250, BSA was used as standard 
for the preparat ion of ca l ib ra t ion curve. The dye reagent 
was prepared by dissolvinglOO mg coomassie b r i l l i a n t blue 
G-250 in 50 ml of 95% ethyl alcohol. 100 ml of 85% (w/v) 
orthophosphoric acid was added to t h i s so lu t ion . Most of 
the dye dissolved in phosphoric acid and the r e su l t i ng red 
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coloured solut ion was f i na l ly di luted to one l i t r e with 
d i s t i l l e d water. The dye was f i l t e r e d through a 
Whatman No. 1 paper before use. 
Protein solut ions of appropriate d i lu t ions were 
placed in t e s t tubes and adjusted to a f ina l voliime of 
0.1 ml with 0.05M Tris-HCl buffer, pH 8 . 5 . 5.0 ml of the 
dye reagent was added and the contents were Vortexed. 
The absorbance was measured af te r 5 minutes a t 595 hm 
aga ins t a reagent blank. Blank was prepared by mixing 
0.1 ml of the buffer and 5.0 ml of dye reagent , 
(b) Method of Lowry _et a l : Suitable a l iquots of p ro -
t e i n solut ions were d i lu ted to 1.0 ml with d i s t i l l e d 
water. To t h i s was added 5.0 ml of freshly prepared copper 
reagent (prepared by mixing one pa r t of 0,55^ w/v copper 
su l fa te in ^% sodium potassium t a r t a r a t e amd 50 pa r t s of 
2% w/v sodium carbonate in 0.1N sodium hydroxide). 
After incubation a t room temperature for 10 minutes, 0.5 
ml of IN Folin-phenol rSagent was added and the tubes 
were ins tan t ly Vortexed. Absorbance of the blue colour 
was measured af ter 30 minutes a t 660 nm agaihst a reagent 
blank in a Bausch and Lomb Spectronic 20 spectrophoto-
meter. 
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Polyacrvlamide Gel Electrophoresis . •. PAGE was 
performed essentially, according to the method of Laemmli 
(1970) using slab gel apparatus manufactured by Atto Co., 
Japan. Concentrated stock solutions were mixed in the 
appropriate order and proportions to give a final concen-
tration of ^% acrylamide. It was then poured into the 
mold formed by two glass plates (16 x 14 cm) separated by 
2mm thick spacers. Bubbles and leaks were avoided, A 
comb, providing a template for 10 sample wells, Was in-
serted into the stacking gel solution before polymeriza-
tion began. When the polymerization was complete in about 
2 hours, the comb was removed and wells were overlaid with 
the running buffer. Samples containing 50 jug of protein 
mixed with bromophenol blue and 109^  sucrose were applied 
to the wells of the slab gel. Electrophoresis was per-
formed at 100 V till the tracking dye reached the bottom 
of the gel. After the electrophoresis was complete, the 
gels were stained for protein in 0.04% coomassie brilliant 
blue G-250, 3.5% perchloric acid, 20% methanol solution 
for 2-3 hours. Excess dye was removed by destaining the 
gels in 10% acetic acid, 20% methanol solution. 
For estimation of enzyme activity in the gels, 1 cm 
unstained 
slices of the/gel were cut with the help of a razor blade. 
Each slice was crushed and homogenized in 2,0 ml of 0,05M 
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Tris-HCl buffer, pH 8.5 and l e f t overnight a t 4° . Enzyme 
assay was performed using su i tab le a l iquots of the buffer. 
SDS Polyacrylamide Gel Electrophoresig - This was based 
on the procedure described by Fairbanks ^ a^. (1971) and 
Davis (1964), 6% polyacrylamide gels were used. Other 
d e t a i l s for polymerization were the same as for the non-
denaturat ing system except the polymerization which was 
allowed to proceed for 12 hours a t 20°. The gel s lab was 
stained for prote in with coomassie b r i l l i a n t blue R-250 
(Fairbanks et a l . , 1971). The slab was placed in p e t r i 
p l a t e s to which were added the f ix ing, s ta in ing and des-
ta in ing so lu t ions . The solut ions were kept a t 37° for the 
s ta ted time. The gel was suspended in a solut ion of 
0.025-0,05% coomassie blue in 25% isopropyl alcohol and 
10% acet ic acid overnight, then in solutions containing 
10% isopropyl alcohol, 10% acet ic acid and 0,0025-0.005% 
coomassie blue (6-9 hours)* After t h i s , the gel was 
t rea ted with a solut ion of 10% acet ic acid and 0,0025% 
coomassie blue and allowed to stand overnight. The gel 
was f ina l ly destained with 10% acet ic acid. 
Immunological Studies -
(a) Immunization of rabbi t against pur i f ied ASA es te rase : 
1.0 ml of pur i f ied ASA es terase (2 mg/ml) in O.OIM phosphate 
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buffer, pH 7.5 containing 0,15MNaCl (PBS) was mixed with an 
equal volume of x^'CA. 6-9 months old male rabbits were 
injected weekly for 4 weeks with 2.0 ml of freshly prepared 
protein-FCA suspension. Each rabbit received a total of 
8 mg protein in the course of 4 intramuscular injections. 
The animals were given one booster injection at a 2 week 
interval with the same amount of antigen and bled by cardiac 
puncture, 45 days after the first injection. The immune 
sera were stored in small aliquots at -20 with 0,1% sodiiM 
azide. 
(b) Immunodiffusion: The precipitin reactions were per-
formed by Ouchterlony double diffusion principle, according 
to the method of Tan and Kunkel (1966) using glass petri 
dishes. 5.0-6.0 ml of molten, filtered 0,4?^  agarose in 
PBS containing 0,19^  sodium azide was poured onto 50mmx15mm 
glass petri dishes and allowed to harden at room tempera-
ture, 5 mm wells separated from each other by 10 mm were 
cut from their centers. The petri dishes were stored at 
4°. 
All the sera tested were decomplemented by heating 
at 
them/56 for 3 minutes, 25 yUl of serially diluted sera 
were placed in peripheral wells and antigen in the central 
well or vice versa, ^ e reaction was allowed to proceed 
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fo r 24-28 hours in a moist chamber a t room temperature, 
P e t r i dishes were washed with 5% sodium c i t r a t e for 1 
hour to remove any non-specific p r e c i p i t i n l i n e s . The 
p r e c i p i t i n l i ne s were analyzed v isual ly and r e s u l t s 
recorded. 
(c) Counter-immunoelectrophoresis (CIE): CIE was pe r -
formed, according to the method of Kuranta and Tan (1976), 
with s l i g h t modification. 3.0 ml of 0,6?^ agarose 
(prepared in 0,025 M ba rb i t a l buffer, pH 8.4 containing 
0.1% sodium azide) was p ipet ted onto alcohol cleaned 
microscopic s l ides (25mm x 75mm) and allowed to so l id i fy 
a t ix)om temperature. The s l ides were stored in a moist 
chamber a t 4*^  and used within 3 days. On each s l ide a s e t 
of wells was cut with a 4 mm diameter punch. The wells 
were arranged in 3 p a r a l l e l rows vz-ith two wells in each 
row. The distance between the circumferences of 2 wells 
was 4-5 mm. 
Antigen was placed in the cathodal wells and 
decomplemented serum in the anodal wells (20 jul in each 
w e l l ) . Electrophoresis was performed in 0,05K b a r b i t a l 
buffer, pH 8,4, with a current of 3-4 mA per s l i d e . Each 
run had a well containing 20 jul of 0,25 mg/ml bromophenol 
blue as marker. After the marker had migrated approxi-
mately 15mm from the center of th i s wel l , e lectrophoresis 
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was stopped. This migration took 30-40 minutes. The 
s l i des were examined and r e s u l t s recorded. The s l i de s 
were then l e f t overnight in a moist chamber a t room tem-
pe ra tu re . Most of the p r e c i p i t i n l i nes developed only 
af te r overnight incubation. Non-specific p r e c i p i t i n 
l i n e s were abolished by washing the s l i des with 5^ sodium 
c i t r a t e for 1 hour, 
(d) Enzyme linked immunosorbent assay: The technique 
of Voller e t al, (1976) with s l i g h t modification was used 
for detect ion and quant i ta t ion of anti-ASA es te rase a n t i -
body on polystyrene p l a t e s . The de t a i l s of the procedure 
are as follows: 
3 /ug/0.25 ml antigen in coating buffer (0.1M 
bicarbonate buffer, pH 9.6 containing 0,02% sodium azide) 
was added to the wells of micro t i te r p l a t e which was then 
incubated overnight a t 4 , The wells were washed 4 times 
with ST-20 (0,15M NaCl, 0,5 ml Tween-20/litre, pH 7.0) 
and unoccupied s i t e s were saturated by the addition of 
1% BSA in ST-20 followed by incubation at 4^ for 16 hoiors. 
After washing the p l a t e with ST-20, 0,25 ml of d i lu ted 
antiserum was added and the p la tes were incubated at 37^ 
off 
fo r 2 hours. After washing the excess antibody/with ST-
20, the p la t e was once again incubated a t 37° for 1 hour 
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with 0.25 ml of goat -ant i rabbit IgG a lka l ine phosphatase 
conjugate (1:1000 d i lu t ion in ST-20), At the end of the 
incubation the p la te s were emptied and washed.0.2 ml of 
subs t ra te (p-NPP, 5x10 M^ in 1,0 M diethanolamine buffer, 
pH 9.8 containing 100 mg/ l i t re MgCl2.6H20 and 0.029^ sodium 
azide) was added into each wel l . The p l a t e was again i n -
cubated a t 37° for 1 ho\ar for colour development. The r e -
act ion was f i na l ly stopped by the addition of 0.1 ml of 
3N NaOH and the contents of each well were read a t 400 nm 
on a Spekol-10-spectrocolorimeter (Veb Carl Zeiss Jena, 
F.R.G.) . Results were expressed as '^test'"'^control* 
Determination of Sulfhydryl Groups; The method used was 
e s sen t i a l ly t ha t described by Ellman (1959). For the 
determination of the exposed SH groups^the pro te in 
(0.01-0.04 jumole) was dissolved in 6,0 ml of O.OSM T r i s -
HCl, pH 8.5 and 0.5 mg/ml EDTA. In order to achieve the 
denaturat ion of prote in and quant i ta te the t o t a l riumber 
of SH groups^the prote in was dissolved in the above des-
cribed solut ion containing 2^ SDS. To 3.0 ml of the so lu -
t ion was added 0.1 ml DINB solut ion (40 mg DTNB in 10 ml 
of 0.1M Tris-HCl, pH 8.0) and the colour developed was 
read a t 410 nm against a water blank af te r 15 minutes. 
The remaining 3.0 ml served as the blank for the p ro te in 
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and SDS, A reagent blank was used to account for the 
absorption of the reagent at 410 nm. SB. content was calcu-
lated using Sy value of 13,600, The colour yield was un-
affected by the presence of SDS and was independent of the 
pH between pH 7,0 and 8.0. 
Determination of Acetylcholinesterase Activity - The 
activity of acetylcholinesterase was determined^according 
to the procedure of Hestrin (19^9). To 0,5 ml of purified 
enzyme, was added 0.5 ml of0.004M acetylcholine iodide solu-
tion in 0,06M phosphate buffer, pH 7.2, The reaction was 
incubated at 37 for 15 minutes. 2,0 ml of alkaline hydro-
xylamine reagent was added and pH of the reaction mixture 
was brought to 1.2 + 0.2 with 1.0 ml of 3.5N HCl solution. 
Alkaline hydroxylamine reagent was prepared freshly before 
use by mixing equal volumes of 2.0M hydroxylamine hydro-
chloride and 3.5 N sodium hydroxide, 6,0 ml of colour re-
agent (0.37N ferric chloride prepared in 0,1N HCl) was 
finally added and colour developed read at 5^0 nm. The rate 
of acetylcholine hydrolyzed was calculated from the standard 
curve. Enzyme activity was expressed as jumoles of acetyl-
choline hydrolyzed/ml/hour. 
Acetylcholinesterase activity was also measured 
spectrophotometrically using acetylthiocholine iodide 
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as subst ra te (Biochiniica Information, Boehringer 
Mannheim). 3.0 ml of 50 mM phosphate buffer, pH 7.2 , 
containing 300 pg DTNB was mixed with 0.1 ml of 5 mM 
acetyl thiochol ine iodide solut ion. The reac t ion was 
s t a r t ed by the addit ion of 0.02 ml ASA es te rase . The 
change in op t ica l density a t 405 nm per uni t time gave 
a measure of acetylchol inesterase a c t i v i t y . 
Measurement of Proteolyt ic Activi ty - Assay of p ro -
t e o l y t i c a c t i v i t y Was performed by the casein d iges t ion 
method, described by Kunitz (1947) with some minor modi-
f i c a t i o n s . ASA esterase (0.5 ml) was preincubated a t 
37° for 5 minutes in 0,05M Tris-HCl, pH 7 .5 . 6*5 ml of 
2% (w/v) casein solut ion prepared in the same bxiffer 
was added and the mixture was incubated a t 37°• The un-
digested casein was prec ip i ta ted by the addit ion of 0.5 
ml of 10% (w/v) TCA so lu t ion . The p r e c i p i t a t e was 
allowed to stand a t room temperature for 15 minutes. 
Following centr ifugation a t 3,000 rpm for 10 minutes, 
su i t ab le al iquots of the supernatant were analysed by 
the Folin-phenol reagent (Lowry e t a l . . 1951). ^ 
iBMDobilization of Purified ASA Esterase on Sepharose 4B-
Sepharose 4B was act ivated as described by Pbrath et a l . 
(1967). 10 gm of Sepharose 4B was washed thoroughly with 
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distilled water in a sinterred glass funnel. The gel was 
drained off excess bxiffer and suspended in 10 ml of 2.0M 
sodium Carbonate. 5.0 ml of distilled water was added 
and mixed thoroughly by placing on a magnetic stirrer. 
1.5 gm cyanogen bromide (CNBr) dissolved in 1,0 ml aceto-
nitrile was added to the beaKer containing Sepharose and 
mixed thoroughly in cold for 10 minutes. The whole mass 
was transferred immediately to a glass sinterred funnel 
and washed thoroughly with 0.1M bicarbonate buffer, pH 
8.5, distilled water and once again with the buffer. 
After thorough washing the activated Sepharose was dried 
and resuspended in 24 ml purified ASA esterase solution 
(250 units) prepared in 0.05M phosphate buffer, pH 7.5. 
This was then stirred for 6 hours in cold. The Sepharose 
matrix with bound ASA esterase was separated by centrifu-
gation and enzyme activity as well as protein in the 
supernatant was quantitated in order to calculate the 
amount of enzyme immobilized. The ASA esterase bound 
matrix was thoroughly washed with O.OS.MTris-HCl buffer, 
pH 8.5. The preparation was finally stored in the same 
buffer. Attempts were made to increase the retained 
activity of the immobilized preparation by including ASA 
in the ASA esterase solution added to the matrix. This, 
however, did not significantly effect the retained acti-
vity of the immobilized preparation. 
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Photography; Gels stained with coomassie brilliant 
blue R-250 were photographed on ORWO, ASA 125 film under 
illumination using a yellow filter; Immunodiffusion 
gels were photographed similarly after proper position-
ing of petri plates against illuminator. 
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I. DISTRIBUTION OF ASA ESTERASE IN HUMAN BLOOD 
Most of the available work on blood ASA esterase 
concerns the plasma or serum enzyme (see Rainsford §t ^,, 
1980), Costello and Green (1982) reported that hvman 
RBCs exhibited significant ASA hydrolyzing activity. As 
shown in Table I, ASA esterase activity of RBC is consi-
derably higher than that of plasma, RBC contained about 
8-fold higher ASA esterase activity as compared to plasma 
and about 4 times more activity than the same volume of 
whole blood. Only a small fraction of the RBC ASA esterase 
was associated with the membrane. As evident from Table-
II, extensively washed ghosts contained only about 13% of 
the RBC ASA esterase activity while over 61% activity could 
be localized in the membrane-free hemolyzate, 
II. PURIFICATION OF HUMAN RBC ASA ESTERASE 
(A) Aimnonium Sulfate Fractionation - In the initial 
experiments attempts were made to employ ammonium sulfate 
fractionation as the first purification step. This, how-
ever, resulted in anamolous results and significant ASA 
hydrolysis was observed even in the sijpernataiit obtained 
from 100% saturated solutions. Closer examination reveal-
ed that non-enzymatic ASA hydrolysis occurs to a signifi-
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TABLE - 1 
Dis t r ibut ion of ASA Esterase Activity In Hurngm Blood. 
Freshly obtained c i t r a t ed human blood was 
centrifuged' to separate plasma and RBCs, Suitable 
a l iquots of plasma were dialyzed against 0,05M T r i s -
HCl buffer, pH 8 .5 . Act ivi ty of whole blood, plasma, 
washed RBCs and dialyzed plasma was determined as 
described in the t e x t . 
Sources ASA esterase ac t iv i ty 
(Units/ml; 
Whole blood 0,51 
Plasma 0,25 
Red blood c e l l s 2.06 
Dialyzed plasma 0.40 
Each value represents the average of 7 experiments 
performed in dupl ica tes . 
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TABLE - I I 
Dis t r ibu t ion of ASA Esterase in Human RBCs . 
RBCs isola ted from freshly obtained blood were 
used . 1,0 ml of RBCs were hemolyzed by adding 4,0 ml of 5 mM 
Tris-HCl buffer, pH 7 .5 . The hemolyzate was centrifuged 
and the ghost-free supernatant i so la ted . The ghosts 
were washed extensively with the isotonic buffer as des-
cribed in the t e x t . RBC ASA es terase a c t i v i t y was taken 
as 100 for the ca lcula t ion of percent a c t i v i t y of the 
hemolyzate and the ghosts. 
source ^ ^ J L ^ ^ S ? ^ « Act ivi ty (Units/ml) 
Red blood ce l l s 3.71 lt)0 
Kembrane-free 2.25* 61 
hemolyzate 
Ghosts 0.49 13 
* Corresponds to the value of membrane-free hemolyzate 
obtained from 1,0 ml RBCs. 
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cant extent in presence of ammonium sul fa te (Figure 2 ) , 
especia l ly a t a lkal ine pH (Figure 3 ) . Ammonium su l fa te 
f rac t iona t ion was, therefore , not used in the subsequent 
s t ud i e s , 
(B) D£AE~Cellulose Chromatography - RBC ASA es terase 
was purif ied using DEAE-cellulose chromatography as the 
f i r s t chromatographic s t e p . A 3.5 x 30 cm column was 
packed and operated as described in Methods. The column 
was eluted with a l inear gradient of 0,2M to 1.0M sodium 
chloride in 0.05M Tris-HCl, pH 7 . 5 . Enzyme a c t i v i t y 
appeared as a s ingle symmetrical peak between 0.33 to 
0,44M concentration of sodium chloride which was also co-
inc iden ta l with the major prote in peak (Figure 4 ) , 
(C) Sephadex G-200 Gel F i l t r a t i o n - Figure 5 represents 
the e lut ion prof i l e of ASA es terase on the Sephadex G-200 
column. The enzyme was eluted as a s ingle peak followed 
by a major prote in peak which exhibited no enzyme a c t i v i t y , 
PMSF was incliided in t h i s step a l so . When the DEAE-
purif ied ASA esterase was passed through Sephadex G-200 
coliimn in the absence of FMSF in the i so la t ion buffer, 
y ie ld of the enzyme decreased to about 10?6, Inclusion of 
1mK H4SF in the i so la t ion buffer afforded 37% recovery of 
enzyme in t h i s s tep . 
Figure - 2. Effect of Ammonium Sulfate on ASA Hydroly-
s i s a t pH 9.0. 
In a t o t a l volume of 3.0 ml, the react ion 
mixture contained 0.05 M Tris-HCl buffer, 
pH 8 ,5 , 10-40% ammoniiM sul fa te and 
16.65 mKj of ASA, The mixture was incu-
bated for one hour a t 37 . The react ion 
\vas terminated by adding 3.0 ml of HgClp-
Fe(N0,), reagent and the r e su l t i ng colour 
was measured a t 540 nm. Samples contain-
ing same amounts of ASA and buffer but no 
ammonium sul fa te during the incubation 
served as reagent blanks. Ammonium s u l -
fa t e was added to the blank tubes a f t e r 
the addit ion of the colour reagent. 
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Figure - 3 . Effect of pH on Ammonium Sulfate Induced 
ASA Hydrolysis. 
Hydrolysis of ASA in presence of 15% 
ammonium sul fa te between pH 6 , 0 - 9 . 0 
was inves t igated. Tris-HCl buffer 
was used. pH of a l l the solut ions 
including tha t of the subs t ra te was 
pre-adjusted to the appropriate value. 
Other de t a i l s of the experiment are 
described in the legend t o Figure 2. 
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Figure - 4. DEAE-Cellulose Chromatography. 
A 3.0 X 30 cm column was used, RBCs 
were hemolyzed in cold d i s t i l l e d water 
and the hemolyzate was added to the 
ce l lu lose matrix. The matrix was tho-
roughly washed on a Blichner funnel 
with the Tris-HCl buffer t i l l superna-
t a n t was free of proteins (as indicated 
by lack of absorbance a t 280 nm). The 
s lur ry was loaded on the column and 
packed with the same buffer a t a flow 
ra te of 35 ml/hour, Elution was per -
formed using a sodium chloride l i nea r 
gradient of 0,2M to 1,0M, 5.0 ml 
f ract ions were col lected and ASA e s t e -
rase a c t i v i t y as well as pro te in con-
cent ra t ion (Bardford, 1976) was measur-
ed. 
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Figure - 5. Sephadex G-200 Gel F i l t r a t i o n . 
ASA es terase f ract ions col lec ted 
from DEAE-cellulose column were 
pooled,, concentrated, dialyzed and 
applied on Sephadex G-200 column 
(2 .5x80 cm), previously e q u i l i b r a -
ted with 0.05M Tris-HCl buffer , 
pH 7 .5 . The column was eluted with 
the same buffer containing 1 mM 
PMSF and 5.0 ml fract ions were 
col lec ted . Alternate f rac t ions were 
assayed for ASA esterase a c t i v i t y 
and prote in concentration (Bradford, 
1976). 
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The purification of ASA esterase from the hijman 
RBCs is summarized in Table III, The enzyme was purified 
226-fold with a yield of about 37%. Specific activity of 
the homogeneous preparation varied between 2,0 to 3.1 
units/mg of protein among the various batches of purifi-
cation. 
III. HOMOGEl^ SITY 
Homogeneity of ASA esterase was determined by poly-
acrylamide gel electrophoresis as well as immunologically. 
Slab gel electrophoresis was performed both in pre-
sence or absence of SDS. The crude hemolyzate showed a 
single diffused hemoglobin band in 5% acrylamide gels 
(Figure 6, lane A), Upon purification through D£)A£-cellu-
lose, a prominent band corresponding to pure ASA esterase 
and a very fast moving band in addition to several faint 
bands were observed (lane B), The additional bands were 
removed after gel filtration on Sephadex G-200 and a single 
sharp band was obtained (lane C), 
In order to locate ASA esterase activity in the gels, 
the gels were sliced, homogenized in buffer and fil-
tered. The filtrates were used for the determination of 
ASA esterase activity, ASA esterase activity corresponded 
with the coomassie blue staining region in the gel. No enzyme 
Figure - 6. Polyacrylamide Gel Electrophoresis , 
The e lec t rophore t ic pa t terns of diffe-
rent preparat ions of ASA es te rase in 
6% gels without SDS are shown, 50 ;ag 
of each preparation was electropho-
resed on the slab gel a t room tempera-
ture (25°) using a current of 100 V. 
Lane A: Crude enzyme. 
Lane B: DEAE-cellulose f rac t ion . 
Lane C: Sephadex G-200 f r ac t ion . 
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a c t i v i t y could be detected in other regions of the gel 
(Figure 7 ) . 
For immunological s tud ies , r abb i t s were immunized with 
pur i f ied ASA esterase in FCA. In immunodiffiision and 
counter-immunoelectrophoresis the rabb i t immune sera exhib i -
ted p r ec ip i t i n l i nes with puri f ied (Figure 8) or crude a n t i -
gens (Figure 9 ) . Antibodies agains t ASA es terase were found 
to be absent in pre-immunized animals. 
Because of high s e n s i t i v i t y , ELISA was adapted for 
the detection and quant i ta t ion of anti-ASA es terase an t ibo-
d i e s . The technique involves the adsorption of ASA es terase 
to the surface of mic ro t i t e r p la tes and sa tu ra t ion of excess 
s i t e s with BSA, The p la tes were f i r s t incubated with immune 
sera and a f t e r antigen-antibody reac t ions , the immune-
complexes were detected by enzymatic react ion involving goat-
a n t i - r a b b i t IgG alkal ine phosphatase conjugate. Measurement 
of enzyme a c t i v i t y was f a c i l i t a t e d by the use of p.-NPP as 
subs t r a t e , Pre-immunized and ASA es terase immunized rabb i t 
sera were tes ted a t d i f fe ren t d i lu t ions s t a r t i n g from 1:100. 
Immunized sera showed a strong pos i t ive reac t ion in ELISA 
with ASA es terase (Figure 10). Pre-immunized sera exhibited 
very poor r e a c t i v i t y . 
Figure - 7. Location of ASA Esterase Activity 
in Polyacrvlamide Gels, 
The purified enzyme was subjected to 
PAGE as described earlier. One lane 
of the slab gel vias stained with 
coomassie blue while other lanes 
were sliced transversely (1 cm slices). 
The slices were homogenized and eluted 
overnight with 2.0 ml of 0.05 M Tris-
HCl buffer, pH 8.5 at 4°. ASA esterase 
activity was determined in 1.0 ml 
aliquots of the buffer extract. 
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Figure - 8. Immunodiffusion of Antiserum Prepared 
from Pure ASA Esterase. 
Antisera were raised by injecting male 
rabbits with purified antigen (2 mg/ml) 
alongwith FCA, Weekly injections were 
given and after four weeks the animals 
were bled and the cross-reactivity of 
the antigen with antisera was tested 
by immunodiffusion as described in 
Methods , Well 1 contained immunized 
serum and wells 2 and 3 contained pre-
immunized sera. 

Figure - 9. Inununodiffusion of Antiserum Against 
Crude Antigen. 
The cen t ra l well A was loaded with 2^ pi 
of antiserum ra ised against pur i f ied ASA 
es t e r a se . The c ross - reac t iv i ly of a n t i -
serum was checked by immunodiff\ision by-
applying d i f fe ren t concentrations of 
crude antigen preparation (RBC lyza te) 
to the wells 1,2 and 3 . Well 4 was 
loaded with pre-immunized serum. 

Figure - 10. ELISA of Anti-ASA Esterase. 
Pre-immunized and ASA es terase 
immunized rabbi t sera were tes ted 
by ELISA a t d i f ferent d i l u t i o n s . 
The d i lu t ions of an t i sera taken 
were 1:100, 1:200, 1:400, 1:800, 
1:1600, 1:3200, 1:6400, 1:12800, 
1:25600 and 1:51200. The wells 
were coated with a solut ion con-
ta in ing 3 p-g protein/0,25 ml of 
0.1M bicarbonate buffer, pH 9.6. 
The antilogarithm of serim d i l u -
tioxis versus the absorbance a t 
^ 0 ^ ^^es t -^con t ro l^ ^ ° ^ ^ ° ^ ^ 
immunized ( O ) and preimmuniz-
ed ( # ) sera was plot ted as 
shown. 
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IV. PROPERTIES OF PURIFIED ASA ESTERASE 
(A) Molecular Weight - The molecular weight of the p u r i -
f ied ASA esterase was determined by gel f i l t r a t i o n on 
Sephadex G-200 (Andrews, 1964), as well as by PAGE perform-
ed in presence of SDS, For gel f i l t r a t i o n s t ud i e s , a 
2 , 6 x 8 1 cm column was equi l ibra ted with 0,05M Tris-HCl 
buffer, pH 7 .5 . The column was ca l ib ra ted with ca ta lase 
BSA, ovalbumin, cytochrome C and ribonuclease of known mole-
cu la r weights. About 2 mg of puri f ied enzyme was chromato-
graphed on the same column and e lut ion was performed with the 
equ i l ib ra t ing buffer, 5.0 ml f ract ions were col lec ted a t a 
flow ra te of 15 ml/hour. The elut ion prof i les o f blue dex-
t r a n , marker proteins and ASA esterase are shown in Figure 
1 1 , The e lu t ion volume (Ve) of a given solu te zone was 
taken in a l l cases as the eff luent peak pos i t ion of the 
so lu t e s . The void volume(Vo) was calculated by measuring the 
effluent peak posi t ion of the blue dextran 2000, A p lo t of 
Ve/Vo versus logarithm of molecular weight, according to the 
procedure of Andrews (1964), g^ve a s t r a i ^ t l i ne (Figure 12). 
The molecular w e i ^ t of ASA esterase^ calculated from th i s 
data as described by Andrews (1964),was 1,26,000. 
SDS electrophoresis in presence of 0.296 SDS revealed 
s ingle 
a / d i s t i n c t band (Figure 13). The molecular weight of the 
polypeptide was calculated from the mobility of the peptide 
Figure - 11. Gel F i l t r a t i o n Profi le of Standard 
Proteins and ASA Esterase on 
Sephadex G-200, 
10 mg of each of the marker proteins 
and 2 mg of the purif ied ASA es te rase 
were chromatographed on a 2.6 x 81 cm 
column of Sephadex G-200, equi l ib ra ted 
with 0.05M Tris-HCl buffer, pH 7 . 5 . 
5.0 ml f rac t ions were col lec ted a t a 
flow ra te of 15 ml/hour. Protein 
concentration was estimated by the 
procedure of Lowry et a l . (1951). 
(A) Blue dextran 
(B) ASA esterase 
(C) BSA 
(D) Ovalbumin 
(E) Ribonuclease 
(F) Catalase 
(G) Cytochrome C 
(luu/s^iunjAjiAipD esDjeise VSV(o) 
s 
0 
E 
2, o 
> 
c 
o 
ixl 
d o 
^JU099P^^UDqJOsqv (•) 
Figure - 12, Determination of Molecular Weight 
of Purified ASA Esterase. 
The data from Figure 11 was plotted 
as described by Andrews C1964), 
Void volume (Vo) was determined using 
blue dextran. The ratio of elution 
volume (Ve) to(Vo) was plotted 
against the logarithm of molecular 
weights of the marker proteins: 
(1) cytochrome C (11,700), (2) 
ribonuclease (13,700), (3) ovalbumin 
(43,000), (4) BSA (69,000) and (5) 
catalase (2,40,000). Position of the 
ASA esterase is marked by an arrow. 
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Figure - 13. SDS Polyacrylamide Gel E lec t ro -
phoresis of the Purified ASA 
Esterase . 
The procedure described by Fairbanks 
^ a l . (1971) was followed. The 
pur i f ied ASA esterase (30 )ig) was 
subjected to electrophoresis in 6% 
acrylamide gels containing 0,2?^ SDS 
for 6 hours a t 100 V, Pr ior to e l e c -
t rophores is , the enzyme was denatured 
by heating a t 100° for 5 minutes with 
sanqjle bioffer containing 2Hnercapto-
ethanol , A mixture of marker prote ins 
was also electrophor«sed under i d e n t i -
cal condit ions. 
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by the procedure reported by Weber and Osbom (1969). The 
mobi l i t ies of marker proteins determined imder iden t i ca l 
conditions were p lo t ted a ^ i n s t the logarithm of moleciilar 
weight (Figure 14), Least square analysis of the data 
indicated a l i n e a r re la t ionsh ip between log M and r e l a t i v e 
mobility (Rm), The intense prote in band exhibited mobility 
between t rypsin inh ib i to r and trypsinogen (FMSF-treated), 
suggesting a molecular w e i ^ t of 22,000, This indica tes 
t h a t purif ied ASA esterase cons is t s of approximately s ix 
subuni ts , 
( B ) Influence of pH - The pH dependence of ASA es terase 
was tes ted between pH 4,0 and pH 10, The pH-activity curve 
shows a pH optimum of 9.0 (Figure 15). ASA es terase ac t iv i -
ty increased r e l a t i ve ly slowly between pH 4 ,0 to 7.0 and 
very irapidly between pH 7.0 and pH 9.0 .Fur ther increase in 
pH resul ted in rapid decrease in a c t i v i t y and the enzyme 
retained only 20% of the maximum a c t i v i t y a t pH 10, 
(C) Effect of Temperature - The effect of temperature on 
ASA esterase ac t i v i t y i s shown in Figure 16, The enzyme 
exhibited optimum a c t i v i t y a t 40 and incubation a t h i ^ e r 
temperatures resulted in rapid decrease in a c t i v i t y . At 
the 
70 only 15% of/maximum a c t i v i t y was retained by ASA 
e s t e r a s e . Incubation a t 50 for various time in te rva l s 
Figure - 14. Calibration Curve for the Determina-
t ion of Molecular Weiglit of ASA 
Esterase . 
The ca l ib ra t ion curve was obtained 
by p lo t t i ng log M versus Rm on SDS 
polyacrylamide gel . The molecular 
weight of ASA esterase was determin-
ed from t h i s curve, 
1 . BSA 
2. Albumin egg 
3 . Glyceraldehyde-3-phosphate 
dehydrogenase 
4 . Carbonic anhydrase 
5. Trypsinogen, PM3F treated 
6. Trypsin i nh ib i to r 
7. ASA es terase 
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Figure - 15. Effect of pH on the Act ivi ty of ASA 
Esterase , 
ASA solut ion was prepared in the 
buffers of indicated pH. Using these 
solut ions a c t i v i t y of the enzyme vfas 
determined as described in the t e x t . 
The buffers used for various pH 
ranges were sodiiim ace ta t e , pH 3 . 0 - 5 . 0 
and Tris-HCl, pH 6 . 0 - 1 0 . All the 
buffer solut ions used were 0.2M. 
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Figure - 16, Effect of Temperature on ASA Esterase 
Act iv i ty . 
1,5 units of ASA esterase were used 
for this study. The preparation was 
assayed at the indicated temperature 
as described in the text. The reac-
tion rate obtained at 40 was taken 
as 100 for calculation of percent 
activity. 
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resulted in a gradual decrease in the ASA esterase activity 
(figure 17); 50% o£ the initial activity was lost after 90 
ir.inute incubation. Figtore 18 shows the ef-fect of 15 minute 
incubation at different temperatures on ASA esterase acti-
vity. While incubation of the enzyme at 40^ for 15 minutes 
resulted in loss of very little activity, rapid loss in 
activity was observed at higher temperatures. 
(D) Effect of Ionic Strength - Exposure to high ionic 
strength solution resulted in significant decrease in ASA 
esterase activity, ASA esterase lost about 20% of its acti-
vity at 0.1M and 50% in presence of 0.2M concentration of 
NaCl. Only 5% activity remained when enzyme was incubated 
with 2.0M NaCl solution (Figure 19). 
(E) Effect of Substrate Concentration - Effect of substrate 
concentration on ASA esterase activity was studied by varying 
the concentration of ASA between 0.33-16.65 mM (Figure 20). 
Activity of the enzyme increased almost linearly upto about 
1 mM ASA concentration. Lineweaver Burk plot of the data 
indicated a Km value of 2.85 x 10 M for ASA esterase. 
In order to determine the accessibility of RBC ASA 
esterase to circulating ASA, Km value of the enzyme was deter-
mined using intact RBC as the enzyme source, RBC ASA esterase 
exhibited a marginally higher Km value in comparison to the 
native enzyme. 
Figure - 17. Thermal S tab i l i t y of ASA Esterase . 
1.5 lonits of ASA esterase in 2.5 ml 
of 0.05M Tris-HCl buffer, pH 8.5 
were incubated at 50* ,^ The tubes 
were chi l led a t the indicated 
in t e rva l s and enzyme ac t iv i ty was 
determined as described in the 
t e x t . Activi ty of unincubated 
sample was taken as 100 for calcu-
l a t i on of percent ac t i v i t y . 
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Figure - 18. S t a b i l i t y of ASA Esterase eit 
Different Temperatures. 
1.5 units of ASA esterase were 
incubated for 30 minutes at the 
indicated temperatures, chilled 
immediately and the enzyme acti-
vity determined. Activity of 
the unincubated sample vias taken . 
as 100 for calculation of percent 
activity. 
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Figure - 19. Effect of loniG Strength on ASA 
Esterase Activity. 
1,5 units of ASA esterase were 
incubated with 0.1 - 2.0M NaCl 
solution at 37° for 1 hour and 
activity determined as describ-
ed in the text. 
0-4 0.6 06 1-0 20 
Sodium chloride(M) 
Figure - 20. Effect of Sut)sti^te Concgfiti^tjon on 
Purlf led A3A Ssterage 9,g well as on 
the RBC Enzyme jjx s i t u . 
Purif ied ASA esterase and i n t a c t RBC 
containing ASA esterase were incuba-
ted with various concentrations of 
ASA in 0.05M Tris-HCl buffer, pH 8.5 
containing 0.9?6 NaCl. The t o t a l 
volume of the react ion mixture was 
3.0 ml. Samples were incubated for 
1 hour for the determination of enzyme 
a c t i v i t y as described in the t e x t . 
The data was p lo t ted in the form of 
double reciprocal p lo t and the conven-
t iona l Michaelis-Menten curves ( i n s e t ) , 
( O ) Soluble ASA esterase 
( # ) RBC enzyme in s i t u 
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( F) Effect of Various Chemicals - Various axiions 
exhibited varying degree of inhibi tory effect (Table IV), 
C i t r a t e and phosphate were found to be most inhib i tory 
a t the concentration invest igated, A s l i g h t ac t ivat ion 
was observed when EDTA was included in the reac t ion mix-
t u r e , aizyme t reated with 1 mM and 5njM eserine re ta ined 
80^ and 10% ac t iv i ty , r e spec t ive ly . The enzyme waa i n h i b i -
ted strongly by bis(p-ni t rophenyl) phosphate, 4-ainino 
s a l i c y l i c acid and 5-ainino s a l i c y l i c acid were also found 
to conpletely i nh ib i t the enzyme a t 10 mM concentrat ion, 
(G) Effect of Sulfhydrvl Group Reagents- ASA es te rase 
was found to be SH grov?) dependent. When jfiSA es te rase 
was incubated with various SH group reagents j i t was ob-
served tha t DTNB and HgClp completely inhibi ted tlrie enzyme 
while i t was p a r t i a l l y inhibi ted by iodoacetamide (Table-
V), Incubation of the enzyme with cysteirie-HCl resu l ted 
in about 20% act ivat ion of ASA esterase ac t i v i i y , 
(H) Sulfhydrvl Groups of JSA Esterase - Total number of 
SH groi;?)s of ASA esterase were found to be nine as de te r -
mined using DTNB. Out of these^five were exposed (Table-
VI) . 
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TABLE - IV 
Ef fec t of Various Chemicals on t h e Activj, ty of A3A jSgterase 
Pur i f i ed ASA e s t e r a s e was incubated f o r 10 minutes 
a t 37*^  w i t h the fol lowing chemicals a t the i n d i c a t e d con-
c e n t r a t i o n and enzyme a c t i v i t y determined as desc r ibed in 
t h e t e x t . 
Addi t ion mM % A c t i v i t y 
None 
^3aCl 
NaF 
Sodium c i t r a t e 
Na2S0^ 
CH^CCONa 
NaH^PO^ 
CaCa2 
EDTA 
PMSF 
Ese r ine 
E s e r i n e 
B i s - ( p - n i t r o p h e n y l ) p h o s p h a t e 
4-Amino s a l i c y l i c acid 
5-Amino s a l i c y l i c acid 
10 
10 
10 
10 
10 
10 
10 
10 
10 
5 
1 
1 
10 
10 
100 
89 
73 
42 
97 
94 
51 
98 
113 
80 
10 
81 
21 
0 
0 
67 
TABLE - V 
Effect of Sulfhydrvl Group Reagents on the ASA Js tg rase . 
The assay mixtures were made lOmMwith respect 
to reagents and enzyme a c t i v i t y determined as described 
in the. t e x t . 
Addition mM % Activi ty 
None - 100,00 
DTNB 10 0.00 
HgCl^ 10 0.00 
lodoacetamide 10 45,00 
Nal 10 90,00 
Cysteine-HCl 10 120,00 
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TABLE-VI 
Sulfhydrvl Groups of ASA Esterase. 
The procedure of Ellman (1959) was followed 
for the SH group determination. Protein (0.04 ^moles) 
was dissolved in 6.0 ml of 0.08M Tris-HCl, pH 8.5 and 
0.5 mg/ml EDTA in presence and absence of 2% SDS, 
3.0 ml solut ion served as blank for p ro te in . To the 
remaining 3.0 ml, 0,1 ml of DTOB solut ion was added, 
Absorbance was measured at 410 nm and SH content of 
ASA esterase calculated as described in the t e x t . The 
presence of SDS f a c i l i t a t e d the exposure of buried 
SH groups. 
Moles of SH groups/mole of enzyme 
Total 9.0 
Exposed 5.1 
Buried 3 .9 
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(I) Activity on other Substrates - The ability of puri-
fied ASA esterase to cleave other substrates was also 
investigated. The preparation exhibited significant 
activity to cleave acetylcholine, acetylthiocholine and 
casein. The enzyme exhibited high caseinolytic activity 
with a specific activity of 1.23 units/mg of protein. 
The proteolytic activity of ASA esterase was also found 
to be thiol group dependent (data not shown), 
V. STUDIES ON IMMOBILIZED ASA ESTERASE 
With a view to increase the stability and resis-
tance to various forms of inactivation, ASA esterase 
was immobilized on cyanogen bromide activated Sepharose 
4B, AS shown in the Table VII under the coiiditions em-
ployed, nearly 40^ of the added enzyme was immobilized 
on the matrix. About 46% of the bound activity was 
expressed by the immobilized preparation. 
(A) Effect of PH - The pH- activity profile of native 
and immobilized preparation of ASA esterase is shown in 
the Figure 21, There was no significant variation in 
the pH - activity profile or pH optimum as a result of 
immobilization. 
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Figure - 21 . Effect of pH on the Act ivi ty of 
Native arid Iffimpbilizecl ASA Esterase . 
1.5 uni ts of native and immobi-f 
l ized ASA esterasej^in 0,21^ 1 sodixjm 
aceta te or 0.2M Tris-HCl buffers 
of the indicated pH.were used for 
the study of effect of pH. ASA 
solut ion was also prepared in the 
buffer of appropriate pH, ASA 
esterase assay was performed by 
the standard procedure as d@is*-
cribed e a r l i e r . Values of soluble 
enzyme are taken from Figure 13. 
( O ) Soluble ASA es terase 
( # ) Immobilized ASA es terase 
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(B) Sffect of Temperature - The temperatxxre optimum 
(40°) and temperature-activity profile of ASA esterase 
remained almost unaffected as a result of immobilization 
(Figure 22), Q^Q values of native and immobilized pre-
parations of ASA esterase are shown in Table VIII. The 
Q^Q values do not show any variation between 40-70°, 
while a slight increase in the Q^Q value of immobilized 
preparation was observed between 30-40°. 
The effect of incubation at 50° on the stability 
of the native and immobilized preparations is shown in the 
Figure 23. The immobilized preparation exhibited a signi-
ficant enhancement in stability as compared to the native 
enzyme. As shown in the Figure 23, the immobilized pre-
paration retained about 100?^  activity when incubated at 
50° for 15 minutes ani more than 55% activity was retain-
ed even after 120 minute incubation at the same tempera-
ture. The soluble enzyme lost about 80^ activity in 120 
minutes. 
Figure 24^shows the thermal stability on the native 
and immobilized ASA esterase, Sepharose-bound ASA esterase 
retained more than 90% activity after 30 minute incubation 
at 70°. 
(C) Effect of Urea - Immobilized ASA esterase exhibited 
a very marked resistance to urea induced inactivation 
Figure - 22. Effect of Tempei^turQ on Native ind 
Immobilized ASA gstei^sf. 
1.5 units of the soluble and immobi-
lized ASA esterase preparations were 
incubated at the indicated tempera-
tures and experiment was performed as 
described earlier in Figure 15* 
Values of soluble enzyme are taken 
from Figure 16, 
( O ) Soluble ASA esterase 
( # ) Immobilized ASA esterase 
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TABLE - VIII 
Q^Q Values of Native and Immobilized Preparations of ASA 
Esterase. 
1.5 units o£ native and immobilized preparation 
of ASA esterase were assayed at the indicated tempera-
tures under standard conditions described in the text. 
Tenrperature (°C ) 
Q ^ 
Native Inunobilized 
30 - 40 1.35 1.56 
40 - 50 0.60 0,52 
50 - 60 0.58 0.53 
60 - 70 0.46 0.35 
^ Value represents the r a t i o of the veloci ty a t 
temperature (T + 10) to tha t at T . 
Figure - 23. Thermal S t a b i l i t y o£ Native and 
Immobilized ASA Esterase a t 50 . 
1,5 un i t s of native and immobilized 
ASA es terase in 2*5 ml of O^O^M 
Tris-HGl buffer, pH 0*5 were iiiciuba-
ted a t 50 for the indicated dura-
t ion . The tubes were subsequently 
ch i l led and enzyme a c t i v i t y was 
determined as described e a r l i e r . 
Act iv i ty of the unincubated sample 
was taken as 100 for native and 
immobilized preparat ion,respect ively. 
Data of soluble enzyme v©is taken from 
Figure 17. 
( O ) Soluble ASA esterase 
( # ) Immobilized ASA es terase 
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Figure - 24, Effect o£ temperatare on the S t ab i l i t y 
of Native and Iiroobjlized A3A Elfstgrase. 
1,5 un i t s of nat ive and immobilized 
were 
ASA esterase/ incubated for 30 m,inUtes 
a t the indicated temperatures^ ch i l l ed 
immediately and enzyme ac t i v i t y was 
determined by standard procedure* The 
ac t i v i t y of the unincubated samples 
was taken as 100 for ca lcu la t ion of 
percent remaining a c t i v i t y . Values 
of soluble enzyme are taken from 
Figure 18. 
( O ) Soluble ASA esterase 
( # ) Immobilized ASA esterase 
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(ii'igure 25) . The preparat ion l o s t very l i t t l e a c t i v i t y 
when incubated with increasing concentration of urea and 
re ta ined about 85% ac t iv i ty in presence o£ 6,0Fi urea . The 
soluble preparat ion l o s t over 50?^  ac t iv i ty under these 
condi t ions. Sihancement in the s t a b i l i t y of tiie immobi-
l ized ASA es terase was also evident when the preparat ion 
was incubated for varying time in te rva ls witiri 4.0M urea 
(Figure 26). 
(D) Effect of Trypsin - Effect of various concentrations 
of trypsin on the native and immobilized ASA es terase are 
shown in Figure 27. There was an i n i t i a l rapid decrease in 
the ac t iv i ty of the immobilized ASA es te rase . This was 
followed by a gradual increase in the enzyme ac t iv i ty t i l l 
a t rypsin concentration of 4,2 mg/ml. Incubation with 
higher t rypsin concentrat ions, nowever, caused a marked dec-
rease in ASA esterase a c t i v i t y . Effect of incubation of 
ASA es te rase with 1,7 mg/ml trypsin for various in te rva l s 
i s shown in Figure 28, Under the conditions employed^the 
immoDilized preparation retained 72% ac t iv i t y whereas tiie 
soluble preparation l o s t over 75% ASA es terase a c t i v i t y , 
(E) Effect of Substrate Concentration - Sepharose-bound 
ASA esterase exhibited a Km value which was s l i gh t l y lower 
as compared to tha t of soluble enzyme (Figure 29), The Km 
-* 
v: 
.figure - 25. Effect ot Urea on the S t a b i l i t y of 
Native and Immobilized A3A fisterage, 
1.5 un i t s of nat ive or immobilized 
ASA esterase were incubated in 5.0 ml 
of 0.05MTris-HCl buffer, pH 8.5 and 
made 4,0M with respect to urea concen-
t r a t i o n , Aliquots were withdrawn a t 
the indicated time in te rva l s and a c t i -
v i ty determined as described in the 
t e x t . Act ivi ty of the unincubated 
preparat ions was taken as 100 for c a l -
culat ion of percent remaining a c t i v i t y . 
( O ) Soluble ASA esterase 
( 0 ) Immobilized ASA es terase 
50 90 120 150 180 
Time (minutes) 
Figure - 26. Sfiect or Urea on Native and Iiignobi-
l i zed ASA Esterase. 
In a t o t a l volume of 1.0 ml, 1.5 un i t s 
or native and immobilized ASA es terase 
were incubated Xor 30 minutes a t 37^ 
with urea of the indicated concentra-
t i on . At the end of the incubation, 
enzyme ac t i v i t y was determined as des -
cribed by the standard procedure. 
Act ivi ty of the unincubated prepara-
t ions was taken as 100 for ca lcu la t ion 
of percent remaining a c t i v i t y . 
( O ) Soluble ASA esterase 
( # ) Immobilized ASA es te rase 
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Figure - 27. Effect of Various CoIlcentratio^s 
of Trypsin on Native and Immobi-
l i zed ASA Esterase. 
In a t o t a l volume of 1.0 ml, 1,5 
un i t s of nat ive and immobilized 
ASA esterase were incubated for 
30 minutes a t 37 with indicated 
concentration of t ryps in . At the 
end of the incubation,enzyme 
a c t i v i t y was determined as des -
cribed e a r l i e r . Act ivi ty of the 
unincubated preparat ion was taken 
as 100. 
( O ) Soluble ASA es terase 
( • ) Immobilized ASA es te rase 
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Figure - 28. affect of Trypsin on the 3 t a b i l i t v 
of Native and Igmobilized ASA 
Esterase. 
9,0 mi i t s of nat ive and iinmobilized 
ASA esterase were incubated in 0,05M 
Tris-HCl buffer, pH 8.5 and mixed 
with 30 mg t rypsin a t 37*^  in a t o t a l 
volume of 6.0 ml. 1.0 ml a l iquots 
were removed a t the indicated i n t e r -
vals and ASA esterase was assayed as 
described in the t ex t . Ihe f i na l con-
centra t ion of t rypsin in the assay 
mixture was 1.7 mg/ml. Act ivi ty of 
the unincubated preparat ions was taken 
as 100. 
( O ) Soluble ASA es terase 
( # ) Immobilized ASA es terase 
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Figure - 29. Lineweaver Burk plots of Native 
and Immobilized Preparations oX 
ASA Esterase. 
In a total volume of 3.0 ml, 
1.5 units of native and immobi-
lized ASA esterase were incuba-
ted with indicated concentration 
of ASA and experiment was per-
formed as described in Figure 19, 
The data was plotted in the form 
of double reciprocal plot and 
conventional Michaelis-J^enten 
curves (inset), 
( O ) Soluble ASA esterase 
( # ) Immobilized ASA esterase 
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value of the Insoluble and soluble preparat ions were 
2,22 X 10 -^M and 2.85 x 10 "^ M, respect ively . 
(F) Reusabili ty - Reusabili ty of the immobilized p r e -
para t ion was tes ted by employing a single preparat ion for 
i t s a b i l i l y to hydrolyze ASA repeatedly. At the end of 
each assay)the insoluble preparat ion was separated from 
the assay mixture by centr i fugat ion. This was followed 
by repeated washing of insoluole ASA es terase p r i o r to 
the next assay. The preparat ion as evident from the 
Figure 30 showed good reusab i l i ty and retained over 90% 
ac t iv i t y a f te r 6 assays. 
(G) Storage S tab i l i t y of Immobilized ASA Esterase -
Sepharose-bound ASA esterase showed s ign i f ican t ly higher 
res i s tance to inact ivat ion induced by storage a t 4 upto 
a period of 30 days (Table IX), Longer periods of 
s torage, however, caused higher inact ivat ion and the 
ac t iv i ty of insoluble preparat ion was not s ign i f i can t ly 
d i f fe ren t from the soluble enzyme at the end of 60 days 
s torage , 
a 
(H) Operation of/Laboratory Scale Column of Immobilized 
ASA Esterase - In order to determine the ability of 
immobilized ASA esterase to continuously hydrolyze ASA, 
a laboratory scale column of immobilized preparation was 
Figure - 30, Reusability of the Immobilized 
ASA gsterase. 
1.5 units of immobilized enzyme 
was used for this study. At the 
end of each assay, the prepara-
tions were separated by centri-
fugation and washed thoroughly 
with 0.05M Tris-HCl, pH 8.5 
buffer, fresh assay mixtxjre was 
then added and ASA esterase 
assay was performed as described 
in the text. 
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TABLE - IX 
Effect of Storage at 4° on the Activity of Native and 
Immobilized ASA Esterase. 
12 un i t s of nat ive and immobilized ASA es terase 
preparat ions were stored a t 4 for -the indicated periods, 
Suitable a l iquots were withdrawn and enzyme ac t iv i ty was 
determined af ter various time in t e rva l s . 
ASA esterase a c t i v i t y (%) 
Storage time 
(Days) Native Immobil.ized 
0 100 100 
15 50 75 
50 47 60 
45 47 50 
60 35 40 
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operated, 15 units of immobilized ASA esterase packed in 
a 1 X 5 cm column were used. Different concentrations of 
ASA were continuously passed through the column which was 
operated at a flow rate of 10 ml/hour. The results obtain-
ed are shovm in i-'igure 31. Initially, when 100 ;um ASA 
Was applied to the column, and rate of ASA hydrolysis was 
measured at different time intervals, almost complete 
hydrolysis was achieved even after 7 hours operation, 
V/hen the ASA concentration was increased to 200 ;iyi, then 
initially xj^to a period of 3 hours near about 80% hydro-
lysis was observed which subsequently decrease4 to 6(M at 
the end of the column operation, lAirther decline in the 
rate of ASA hydrolysis was achieved while using 300 ;LIM 
ASA solution. At this concentration only hO% conversion 
was observed after 7 hours of contjjiuous operation of the 
column. 
Figure - 31. Operation of a Laboratory Scale 
Column of Immobilized ASA Esterase* 
15 units of Sepharose bound ASA 
/ 
es terase were packed in a column to 
a bed volume of 14 ml, 100 p.¥i (A), 
200 ;aFi (B) and 300 ;aM (C) ASA 
solut ions in 0.05M I^is-HCl buffer, 
pH 8.5 were continuously passed 
through the colximn, which was opera-
ted a t a flow ra te of 10 ml/hour, 
5.0 ml f rac t ions were col lected and 
extent of ASA hydrolysis ca lcula ted . 
I 20-
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Aspirin is perhaps one of the roost efficacious 
and widely used drug. Despite some fragmentary evidences 
on ASA metabolism and few scattered references to enzyme(s) 
capable of hydrolyzing ASA, there exist relatively few 
systematic stuiies on the metabolic disposition of ASA 
esterase in man and other species. 
The level of ASA in vivo is determined by several 
factors incliJding the rate of absorption of the drug from 
gastrointestinal tract and the rate of its enzymatic hydro-
lysis in tissues and the intravascular compartment (Rowland 
and Riegelman, 1968; Rowland jet al,, 1972), Several eviden-
ces suggest that many beneficial and detrimental effects of 
ASA are mediated by a common pathway Involving tlie effect 
of the drug on prostaglandin biosynthesis and/or release 
(Vane, 1976), Stuiies of Spenney ahd Nowell (1979) demons-
trated thatsalicylates but not ASA stimulated oxygen 
consumption in isolated rat liver mitochondria. Salicyla-
tes inhibited oxidative phosphorylation at low concentra-
tion and at higher concentrations interferred with electron 
transport between coenzyme Q and cytochrome C^, ASA hydro-
lases may thus play a crucial role in determining useful-
ness and/or toxicity of ASA, 
DISCUSSION 
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The altered ASA esterase activity in sera of some 
chronic ASA users may further aggravate the combined 
effect of high intake and of sex-related defects in ASA 
metabolism. It is, therefore, not unlikely that low 
in vivo hydrolyzing activity could be the result of high 
ASA intake as the excess substrate and/or products may 
inhibit the enzyme. This might create a vicious circle 
leading to various harmful effects in the chronic users 
(Gupta and Gupta, 1977). 
Most of the early work related to blood ASA 
esterase has been restricted to the enzyme from plasma or 
serum (Rainsford _et al,, 1980; Morgan and Truitt, 1955). 
More recently, it has been pointed out that whole blood 
contains relatively higher amounts of ASA hydrolyzing 
activity (Harthon and Hedstrom, 1971) and RBC may contain 
significant quantities of the enzyme (Rylance and Wallace, 
1981; Costello and Green, 1982), In si?)port of this, data 
presented in Table I, shows that most of the activity of 
the whole blood resides in the RBCs, 
Most of the RBC ASA esterase, as evident from Table-
II, seems not to be associated with the membrane. This 
clearly suggests that red cell ASA hydrolysis is not due to 
the membrane bound cholinesterase (Costello and (k'een, 1983). 
A small fraction of the activity could, however, be detec-
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ted in the membrane f r ac t ion . This a c t i v i t y could not be 
conpletely eliminated even a f te r repeated washings and may 
be r e l a t ed to the ab i l i t y of chol inesterase to cleave 
ASA (Hofstee, 1951). 
The occurrence of high concentration of ASA es terase 
i n RBC also s ippor ts the e a r l i e r observation of Bastide 
(1955) t h a t whole blood ASA hydrolyzing ac t iv i ty exceeds 
t h a t of serum. I t has also been reported in an e a r l i e r 
study, t ha t Jji v i t r o hydrolysis of ASA in plasma was slower 
than the disappearance of ASA frxjm whole blood jja vivo 
(Leonard, 1962). Our preliminary s tudies indicated tha t 
the membrane may r e s t r i c t to some extent the entry of ASA 
in the RBCs, since ASA es terase ac t i v i t y was found to be 
higher when the RBCs hemolyzed in the assay mixture. Un-
der the assay conditions studied, RBGfahemolyze, making the 
enzyme freely accessible to the subs t ra te . 
Numerous attempts have been made, during the l a s t 
severa l years , to i so la te and purify ASA es terase from 
Variolas sources. Few of these a t t enp t s , however, resu l ted 
in homogeneous prepara t ions . In the present study, ASA 
es te rase has been pur i f ied to homogeneity and several p ro -
p e r t i e s of the enzyme invest igated. 
91 -
Ammonium sulfate f rac t ionat ion has been used as the 
f i r s t step in the pur i f i ca t ion of ASA es terase (Costello 
and Green, 1983). Spenney and Nowell (1979) achieved 3-10 
fold pur i f i ca t ion of rabb i t gas t r i c mucosal ASA es te rase , 
when the crude preparation was prec ip i ta ted between 45-609^ 
sa tu ra t ion of ammonium su l f a t e . Since as shown in Figures 
2 and 3 , s igni f icant ASA hydrolysis occurs non-enzymatically 
in presence of ammonium su l fa te , inconsistencies were obtain-
ed in the r e su l t s when ammonium sulfate f rac t iona t ion was 
used, A pur i f ica t ion of 122-fold could be achieved by 
employing DEAE-cellulose chromatography and the yield of ASA 
es te rase was 63% (Figure 4, Table I I I )o Ion exchange chro-
matography on DEAE-matrices has been successful in the p u r i -
f i c a t i o n of ASA esterase from various other sources; enr ich-
ment in ASA esterase ac t iv i ty from rabbi t ga s t r i c mucosa 
and guinea pig l i v e r was respect ive ly , 33-fold (Spenney and 
Nowell, 1979) and 46-fold (White and Hope, 1984). 
Fract ionat ion of the pooled DEA.E-fr act ions on 
Sephadex G-200 resul ted in a further 2-fold pur i f i ca t ion 
(Figure 5 ) . Inclusion of 1 mM FMSF resul ted in a marked 
increase in the recovery of the enzyme (Table I I I ) , This 
suggested tha t proteolys is even a t the l a s t stage of p u r i -
f i c a t i o n i s a serious problem in the recovery of the enzyme. 
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Indeed, the highly purif ied preparat ion exhibited s i g n i f i -
cant p ro teo ly t ic a c t i v i t y as discussed in the l a t t e r 
sec t ion . The pur i f ied ASA es terase exhibited a specif ic 
a c t i v i t y of 3.1 units/mg of pro te in and appeared homoge-
neous on polyacrylamide gel electrophoresis in presence 
or absence (Figure 6) of SDS. However, the preparat ion 
read i ly developed addi t ional bands,both of higher and 
lower molecular weights on storage a t 0-4 , These baJids 
apparently r e s u l t from pro teo ly t i c degradation and aggre-
gation of the p ro te in . Pur i f ica t ion of RBC ASA es terase 
has also been reported by Costello and Green (1983). The 
spec i f ic a c t i v i t y of t he i r preparat ion was 2,23 units/mg 
of pro te in and the preparat ion obtained a f te r ammonium 
su l f a t e f rac t ionat ions and DEAE-Sephacel chromatography, 
however, was not completely homogeneous. The authors, 
however, claim a pur i f i ca t ion of 930-fold which may 
r e s u l t from the very low specif ic ac t iv i ty of the crude 
hemolyzate. The specif ic a c t i v i t y of the hemolyzate used 
in the present study i s about 5.7 times more than tha t 
reported by Costello and Green (1983). I t i s d i f f i c u l t 
to offer a su i table explanation for the large differences 
between the speci f ic a c t i v i t y of the heroolyzates, observ-
ed in the present study and tha t reported by Costello and 
Green (1983). One reason for the low specif ic ac t iv i ty 
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may be the non-l inear assay conditions enployed by Costello 
and Green (1983). The authors enployed subst ra te concentra-
t ions which were not s ign i f ican t ly higher than Km value of 
the enzyme. The reported low specif ic a c t i v i t y may be par t -
ly re la ted to very high hemoglobin content of the RBC used 
by the authors and to the use of an a l t e rna t ive method for 
p ro te in quan t i t a t ion . Indeed, markedly d i f fe ren t values 
may be obtained when various prote ins are estimated using 
d i f ferent procedures (Saleemuddin and Ahmad, 1984), 
Immunodiffusion (f igure 8) also shows the homogenei-
ty of the prepara t ion . Stored preparat ions of the pur i f ied 
enzyme, however, readi ly gave an addi t ional band,especial ly 
on immunoelectrophoresis^suggesting degradation of ASA 
e s t e r a s e . The anti-ASA es terase antiserum obtained from 
animals immunized with the p\ire enzyme also gave a s ingle 
band with the crude hemolyzate (Figure 9);suggest ing the 
highly specif ic nature of the antibody. As shown from 
Figure 10, the t i t e r of the antibody was also very high. 
The molecxolar weight value of the enzyme calculated 
from the gel f i l t r a t i o n data was 1,26,000 (Figure 12). 
Previously reported values for ASA hydrolases from a v a r i e -
ty of species and t i s sues record molecular weights as high 
as 1,80,000 (Ecobichon and Chow, 1973) and 2,40,000 (Zemer 
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e t a l« , 1975) as well as low molecular weights ranging 
from 55,000 to 70,000 (Ecobichon, 1972). The d ive r s i ty o£ 
the molecular' weights i s probably the r e s u l t of the aggre-
gation (Spenney and Nowell, 1979) and/or the pro teo lys i s 
of the nat ive enzyme molecule. The purif ied RBC ASA es te rase 
migrated as a single band (Figure 13) corresponding to a 
molecular weight of 22,000 in SDS PAGS (Figure 14) . This 
suggests t ha t the nat ive enzyme may be oligomeric being 
made vp of about s ix subunits . The highly inac t iva t ing 
effect of high ionic s t rength (Figure 19) may be re la ted to 
the a b i l i t y of the s a l t to d i ssoc ia te the c a t a l y t i c a l l y a c -
t i v e oligomeric form of the enzyme, Costello and Green 
(1983), however, found no evidence for the existence of sub-
uni t s t ruc ture in ASA esterase using SDS PAGE, 
Khullcir _et a l , (1986) have described an a lkal ine 
es te rase from r a t sub-mandibular glands which exhibited 
s ign i f i can t p ro teo ly t ic a c t i v i t y . The enzyme, though of 
apparently small molecular weight (27,500) was found to con-
t a i n two non-ident ical subunits , ASA esterase also exhibited 
s ign i f i can t p ro teo ly t ic a c t i v i t y as described e a r l i e r , Infac t , 
severa l proteases and es terases exhibit overlapping s p e c i f i c i -
t i e s (Fiyers, 1971), Human RBCs have been shown to con-
t a i n several p ro teo ly t ic enzymes (Pontremoli et ^ , , 1984), 
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Some o£ these require calciiM (Melloni _et a l , , 1984) 
while others do not (Morrison and Neurath, 1953). A few 
of these are located in the cytosol and also act on synthe-
t i c es te r substra tes (Moore et a l . , 1970). I t w i l l be of 
i n t e r e s t to invest igate if the ASA es terase also plays a 
s ign i f i can t p ro teo ly t ic ro le in RBC. 
The pH optimum of RBC ASA esterase was 9.0 
(Figure 15). Aspirin hydrolyzing enzymes reported from 
various sources also exhibited optimal ac t i v i t y in the 
a lka l ine range (Rainsford et a l . , 1980; l^ Fhite and Hope, 
1984; Heymann, 1980). Rabbit gas t r i c mucosa ASA esterase 
exhibited a pH optimum o£ 8,6 (Spenney and Nowell, 1979). 
The temperature optimiM o£ the enzyme was found to 
be 40^ (Figure 16) and the enzyme appeared qui te s table 
a t room temperatures (Figure 17). The Km value of ASA 
es te rase , 2 .85x10 M (Figure 20), was high as compared 
t o the values reported by Costello and Green (1983). 
I t was in te res t ing to note tha t ASA es terase was 
inhibi ted to s igni f icant extent by anions; c i t r a t e and 
phosphate (Table IV), The phosphate has been shown to be 
an inh ib i to r of a ry lsu l fa tase (Dodgson et a l , , 1953). The 
inhibi tory effects of 4-amino s a l i c y l i c acid and 5-amino 
s a l i c y l i c acid were invest igated with a view to develop 
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an af f in i ty column for the pi i r i f icat ion of ASA es t e r a se . 
Since these compounds contain a free amino group^it was 
poss ib le to couple them to glutaraldehyde t rea ted AE-
ce l lu lo se . The matrices obtained using 4 and 5 - amino 
s a l i c y l a t e s were, with or without e s t e r i f i c a t i o n , highly 
effective in binding RBC ASA es te rase . However, the bind-
ing of the ASA es terase was so strong tha t i t was not 
possible to e lu te the enzyme in an active form from the 
matrix. 
The RBC ASA esterase may not be a non-specific 
es terase in view of i t s SH group requirement. Unlike most 
non-specific esterases^the enzyme was highly sens i t ive to 
HgClp^DINB and inhibi ted to s ign i f ican t extent by iodoaceta-
mide (Table V), The enzyme required no metal ions for i t s 
a c t i v i t y (Table IV) and was not s ign i f ican t ly act ivated in 
presence of Ca ++ In this respect the enzyme seems to be 
clearly different from the plasma ASA esterase which is acti-
vated by Ca (Rainsford et al,, 1980), Thiol group require-
ment was also reported for the guinea pig liver ASA hydrolase 
(White and Hope, 1981). Costello and Green (1983) have also 
demonstrated the thiol group requirement of ASA esterase, as 
indicated by its sensitivity to phenanthroline, HgClp and 
DINB, As shown in the Table VI, RBC ASA esterase contained 
nine SH groups, of which five were exposed. This study does 
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not, however, indicate which among these SH groups are 
required for the cataljrtic activity. 
The possibility of ASA esterase being a non-specific 
esterase can also be ruled out in view of the lack of inhi-
bition by NaP and little inhibition observed with 10 mM 
PMSF, The observation that eserine which is a powerful 
inhibitor of acetylcholinesterase was incapable of comple-
tely inhibiting RBC ASA esterase even at 5 mM concentration 
clearly distinguishes this enzyme from acetylcholinesterase. 
In view of the sensitivity of the enzyme to bis-(p-nitro-
phenyDphosphate, ASA esterase may belong to the family of 
carboxylesterases (i^ hite and Hope, 1984), ASA esterases 
have been shown to differ from acetylcholinesterases by the 
lack of effect of calcium and cyanide ions (Glasson, 1951; 
Edwards, 1952) and inhibition by low concentration of DFP 
(Costello and Green, 1982; Spenney, 1978). 
Immobilization studies of ASA esterase were under-
taken in view of tte potential of this enzyme in ASA estima-
tion. Several methods have been used for the estimation of 
ASA in pharmaceutical and biological preparations. These 
include fluorometric determination of ASA (Lange and Bell, 
1966) and direct measurement of ASA (Cotty and Ederma, 1966) 
in blood. Rowland and Riegelman (1967) have also estimated 
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ASA using gas liqiaid chromatography technique. Simultaneous 
spectrofluorometric determination ot ASA and salicylic acid 
in aqueous solution has been demonstrated by Habib and 
Rogers (1985). 
Several simple and sensitive procedures are 
available for the assay of aspirin that are based on the 
estimation of salicylates (Rowland and Riegelman, 1967; 
Kitamura and Majima, 1983). Since the assays involve the 
use of non-enzymatic hydrolysis for the conversion of ASA 
to salicylic acid, precision of the procedures is not very 
high. Quantitative enzymatic l^drolysis of ASA followed 
by estimation of salicylic acid would thus be a useful 
strategy for the ASA assay. Although ASA esterase appeared 
reasonably stable at room temperature, the enzyme was inac-
tivated to a large extent on storage. Attempts were, there-
fore, made to immobilize the purified enzyme and study its 
stability against various forms of inactivation as well as 
its reusability, ASA esterase was immobilized by coupling 
to Sepharose 4B as described by Porath et _^. (1967). While 
the yield of immobilization was reasonable the preparation 
exhibited relatively low-J^  value (Table VII), This may be 
related to the low accessibility of the enzyme immobilized 
on a highly polar matrix to relatively hydrophobic ASA, 
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Alternatively, the large fraction of the immobilized 
molecules may be inactivated due to formation of covalent 
linkage with the matrix through amino groups present at 
or close to the active site. The former possibility does 
not seem to be true as the immobilized ASA esterase did 
not exhibit high M value as compared to the native enzyme 
(Figure 29). Inclusion of ASA during immobilization of 
ASA esterase did not result in a preparation with signifi-
cantly highly value. 
The immobilized preparation showed an unaltered pH-
activity profile (Figure 21), The Sepharose bound ASA 
esterasejhowever, exhibited enhanced stability against 
thermal inactivation at 50^ (Figure 23) and more markedly 
against urea induced inactivation (Figure 25, 26). Increase 
in thermal stability of several enzymes as a result of 
binding to insoluble supports has been demonstrated by 
several workers (Zaborsky, 1973). The enhancement in sta-
bility may be related among other factors to the rigidity 
of the three dimensional structure of the enzyme resulting 
from its attachment to several sites on the matrix. 
Storage stability of ASA esterase was enhanced 
as a result of immobilization on Sepharose 4B and as 
compared to the native enzyme, the immobilized preparation 
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retained significantly greater fractions of the activity 
for 30 days (Table IX), Additional stabilization strate-
gies like crosslinking, etc« might be of further help in 
improving the stabilit/ of the enzyme. The immobilized 
preparation also exhibited good reusability at room 
temperature (Figure 30) and was effective in continuous 
ASA hydrolysis over a period of seven hours. While we 
have not enployed ASA esterase for the actual determina-
tion of the drug these observations strongly suggest the 
potential of the system. Since blood and other tissues 
of Various animals contain ASA esterase (Rainsford _et _al., 
1980; Whitecross et al,. 1977), they may constitute a 
more convenient source for the large scale isolation of 
the enzyme. I^lance and Wallace (1980) have reported 
the inhibition of blood ASA esterase by several drugs 
which are usually administered in combination with ASA, 
It was not, however, demonstrated if these effects were 
primarily related to the inhibition of plasma or RBC 
enzyme. However, it should be possible to overcome liie 
problem of possible inhibition by various drugs and other 
compounds by employing excess ASA esterase. Since the 
immobilized preparation appeared far more resistant to 
proteolysis (Table IX), reusability of the preparation 
should be significant even when exposed to biological 
preparations exhibiting proteolytic activity. 
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The activation of immobilized ASA esterase 
resulting from the incubation with higher concentra-
tions of trypsin (Figure 27) or for longer periods of 
incubation v/ith moderate amounts (Figure 28) is diffi-
cult to explain. The activation may be the consequence 
of enhanced accessibility of the immobilized enzyme 
to aspirin due to the degradation/estimation of non-
catalytic region of the enzyme. 
SUMMARY 
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An enzyme referred to as ' a s p i r i n es te rase ' 
(ASA es terase) brings about the hydrolysis of ASA to 
s a l i c y l a t e and aceta te , ASA esterase i s widely d i s t r i -
buted in t i s sues of higher animals and i s believed to 
p lay a predominant ro le in regulat ing the Jjn. vivo ASA 
l e v e l s in man. 
Most of the ASA hydrolyzing ac t iv i ty of human 
blood was located in the soluble f rac t ion of RBCs, The 
enzyme was piorified using DEAE-celliolose chromatogrgphy 
followed by gel f i l t r a t i o n on Sephadex G-200. DEAE-
ce l lu lose chromatography resul ted in 122-fold pu r i f i c a -
t i o n with a y ie ld of 63%, The preparat ion was pur i f ied 
226-fold with a yield of 37% on subsequent chromiatogra-
phy on Sephadex G-200, The pur i f ied preparat ion appear-
ed homogeneous on polyacrylamide gel e lectrophoresis 
performed in presence or absence of SDS, Additional 
bands, presumably resu l t ing from p ro teo lys i s , however, 
appeared in the preparat ions stored even a t 0-4 for a 
few days. 
The pur i f ied ASA es terase also appeared homoge-
neous on immunodiffusion and counter-immunoelectrophore-
s i s , Anti-ASA esterase an t i se ra exhibited high antibody 
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t i t e r and were foijnd to contain highly specif ic antibodies 
against the enzyme. The antiserum gave a single p r e c i p i -
t i n l ine on immunodiffusion with the crude hemolyzate. 
The molecular weight of ASA esterase determined on 
the bas i s of gel f i l t r a t i o n data was 1,26,000, The enzyme, 
however, migrated as a s ingle band corresponding to a mole-
cular weight of 22,000 on SDS PAGE, suggesting oligomeric 
nature of the enzyme. 
Pur i f ied ASA esterase exhibited a spec i f ic ac t i v i t y 
of 3.1 units/mg of p ro te in . The enzyme was optimally 
ac t ive a t pH 9.0 and 40 . The preparat ion was s tab le a t 
room tenperature for several hours, ASA es terase exhibited 
a Km value of 2,85 x 10 -^M with ASA as subs t ra t e . The 
es te rase contained nine sulfhydryl groi^ps, of which f ive 
were found to be exposed. The enzyme was sens i t ive to 
sulfhydryl reagents and was inhibi ted by HgClp, DTNB and 
iodoacetamide. The enzyme also exhibited s ign i f i can t 
sulfhydryl groi?) dependent p ro teo ly t i c a c t i v i t y , 
ASA es te rase was inhibi ted by eserine^bis-Cp-
nitrophenyl) phosphate, 4-aminosalicylic acid, 5-amlno-
s a l i c y l i c acid, sodium c i t r a t e and sodium phosphate. 
Inh ib i t ion was not complete even with 5 BM eser ine . The 
enzyme was almost conpletely inact ivated in presence of 2.0M 
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NaCl. ASA esterase required no metal ions for i t s a c t i -
v i t y as evident from the lack of any effect of EDTA. 
The enzyme was not act ivated by calcium ions. 
Purif ied ASA esterase was immobilized on CNBr 
act ivated Sepharose 4 B , 46$6 of the added enzyme was 
immobilized under the conditions used and the immobilized 
preparat ion exhibited an t^ value of 0,46, 
The pH-activity and temperature-act ivi ty p r o f i l e s 
of ASA es terase remained unaltered on immobilization. 
However, the immobilized preparat ion exhibited enhanced 
res i s tance to thermal inac t iva t ion and urea denaturat ion. 
The Km values of ASA esterase remained almost unaltered 
as a r e s u l t of immobilization, suggesting good access ib i -
l i t y of the enzyme to ASA, Immobilization also resul ted 
in s igni f icant ly enhanced storage s t a b i l i t y over a period 
of 30 days, A small column of ASA esterase was continuous-
ly operated for a period of 7 hours. The r a t e of ASA 
hydrolysis decreased only to a small extent over the pe -
r iod , especial ly when lower concentrations of ASA were 
used. These s tudies suggest po ten t i a l of immobilized ASA 
esterase in the assay of ASA, 
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